Bioconjugation Market - Global Forecast to 2029
商品番号 : SMB-67655
| 出版社 | MarketsandMarkets |
| 出版年月 | 2024年10月 |
| ページ数 | 677 |
| 図表数 | 1099 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
バイオコンジュゲーション市場は2024年は52億7,000万米ドル規模になることが見込まれ、2024年から2029年までにCAGR15.6%で成長し、2029年までに108億6,000万米ドルに達するとMarketsandMarketsでは予測しています。
バイオコンジュゲーションの市場成長促進要因としてはMarketsandMarketsでは下記要因を挙げています。
- より正確で強力ながん治療に向けたADCなどの標的治療薬の開発における貢献への期待感
- 技術開発とアウトソーシングサービスへの注目の高まり
- 重要な発展機会を持つ新興国におけるバイオコンジュゲーションの用途拡大
「バイオコンジュゲーション市場 – 製品 [消耗品、機器 (クロマトグラフィー、分光測定)]、サービス (結合、分析)、技術 (化学、クリックケミストリー)、生体分子 (抗体)、用途 [治療 (ADC)、研究開発] – 2029年までの世界予測 – Bioconjugation Market by Product (Consumables, Instruments (Chromatography, Spectrometry)), Service (Conjugation, Analytical), Technique (Chemical, Click Chemistry), Biomolecule (Antibodies), Application (Therapeutics (ADC), R&D) – Global Forecast to 2029」は世界の生体共役反応（バイオコンジュゲーション）市場を調査し、主要セグメント別に分析・予測を行ったMarketsandMarkets（マーケッツアンドマーケッツ）の市場調査報告書です。
主な掲載内容
- 市場概観
- 市場力学
- 顧客企業に影響を与える動向／ディスラプション
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- エコシステム分析
- 技術分析
- 特許分析
- 主要会議＆イベント
- 法規制環境
- 投資＆資金調達シナリオ
- ファイブフォース分析
- 主要ステークホルダーと購入基準
- 貿易分析
- 人工知能／生成AIがバイオコンジュゲーションに与える影響
- バイオコンジュゲーション製品のタイプ別市場
- 消耗品
- 器具
- バイオコンジュゲーション製品の技術別市場
- 化学結合
- クリックケミストリー
- 酵素媒介による結合
- 光反応性架橋
- その他の技術
- バイオコンジュゲーション製品の生体分子別市場
- 抗体
- ペプチド
- プロテイン
- オリゴヌクレオチド
- その他の生体分子
- バイオコンジュゲーション製品の用途別市場
- 治療
- 研究＆開発
- 診断
- バイオコンジュゲーション製品のエンドユーザ別市場
- 製薬＆バイオテクノロジー企業
- 開発業務受託機関（CRO）および医薬品製造受託機関（CMO）
- 学術研究機関
- 病院と臨床診断研究室
- バイオコンジュゲーションサービスのタイプ別市場
- カスタム型合成と結合サービス
- 分析＆特性評価サービス
- スケールアップ＆製造サービス
- その他のサービス
- バイオコンジュゲーションサービスの結合タイプ別市場
- 抗体結合
- ペプチド結合
- プロテイン結合
- オリゴヌクレオチド結合
- その他の結合サービス
- バイオコンジュゲーションサービスの技術別市場
- 化学結合
- クリックケミストリー
- 酵素媒介による結合
- 光反応性架橋
- その他の技術
- バイオコンジュゲーションサービスの用途別市場
- 治療
- 研究開発
- 診断
- バイオコンジュゲーションサービスのエンドユーザ別市場
- 製薬＆バイオテクノロジー企業
- 学術研究機関
- 病院および臨床診断研究室
- バイオコンジュゲーションの地域別市場
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- その他の欧州
- アジア太平洋地域
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- その他のアジア太平洋地域
- ラテンアメリカ
- ブラジル
- メキシコ
- その他のラテンアメリカ
- 中東
- GCC諸国
- その他の中東
- アフリカ
- 北米
- 競争環境
- 主要プレイヤ／勝つ権利
- 収益分析
- 市場シェア分析
- 企業評価マトリクス：主要プレイヤ 2023年
- 企業評価マトリクス：スタートアップ／中小企業
- 企業評価＆財政メトリクス
- ブランド／製品／サービス比較
- 競争シナリオ
- 企業情報
Report Overview
The bioconjugation market is expected to grow to USD 10.86 billion by 2029, up from USD 5.27 billion in 2024, at a CAGR of 15.6% between 2024 and 2029.
Several key factors impact the growth of the bioconjugation market. The development of targeted therapeutics such as ADCs is expected to be greatly supported by bioconjugation, as the need for more accurate and potent cancer treatments grows. Furthermore, there is a growing focus on technological developments and outsourcing services. Furthermore, emerging countries provide significant development opportunities, and the expanding applications of bioconjugation are expected to drive the market further.
“The antibody conjugation segment accounted for the largest share of by conjugation type segment for the bioconjugation services market in 2023.”
In 2023, the antibody conjugation segment accounted for the largest share of the global bioconjugation services market by conjugation type. The antibody conjugation segment dominates the bioconjugation services market because it is widely used in developing targeted treatments, particularly for cancer. Antibody-drug conjugates (ADCs) enable accurate drug delivery by targeting specific antigens on tumor cells, minimizing off-target effects and toxicity. The favourable results of ADCs in clinical trials, as well as their approval to treat a variety of malignancies, including HER2-positive breast cancer, have increased demand for antibody-based conjugation services.
“The antibodies segment accounted for the largest share of by biomolecule type segment for the bioconjugation products market in 2023.”
In 2023, the antibodies segment accounted for the largest share of the global bioconjugation products market by biomolecule type. The most prominent biomolecule type in the bioconjugation products market is antibodies, especially monoclonal antibodies, which are dominantly used in the development of Antibody-Drug Conjugates (ADCs) with higher accuracy in targeting. Antibodies are integrally used in oncology and have led to several FDA-approved ADC therapies such as Adcetris and Kadcyla. These therapeutic antibodies conjugated with cytotoxic drugs through bioconjugation techniques allow for targeted treatment while minimizing systemic toxicity. Increasing clinical trials and FDA approvals for the drugs based on antibodies further drive the growth of this segment.
“In 2023, the US remained to dominate the bioconjugation market.”
The US dominated the North American bioconjugation market in 2023. The US is the world’s largest biopharmaceutical market and the leader in biopharmaceutical research and investment. The United States also has a strong healthcare infrastructure, which encourages research and development in the life sciences. Additionally, the significant presence of many biopharmaceutical companies and growing research activities in the biotechnology industry are propelling market growth in the US. Moreover, the growing prevalence of cancer is also driving the growth of the bioconjugation market.
In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the bioconjugation marketplace.
- By Respondent: Supply Side- 70% and Demand Side 30%
- By Designation: Managers – 45%, CXO & Directors – 30%, and Executives – 25%
- By Region: North America – 40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%
Danaher Corporation (US); Lonza (Switzerland); Thermo Fisher Scientific Inc. (US); Merck KGaA (Germany); AbbVie Inc. (US); WuXi Biologics (Cayman) Inc. (China); Sartorius AG (Germany); are some of the key players in the bioconjugation market.
The study includes an in-depth competitive analysis of these key players in the bioconjugation market, with their company profiles, recent developments, and key market strategies
Research Coverage:
This research report categorizes the bioconjugation market by product type (consumables { reagents and kits [linker and crosslinking reagents & kits, labeling reagents & kits, modification reagents & kits, other reagents & kits], labels [fluorescent tags, enzymes, haptens, polymers, bead coupling, other labels], other consumables}, instruments {chromatography systems, mass spectrometers, spectroscopy instruments, flow cytometers, electrophoresis equipment, filtration systems, mixers/shakers, incubators, other instruments}]), technique (chemical conjugation, click chemistry, enzyme-mediated conjugation, photoreactive crosslinking, other techniques), biomolecule type (antibodies, peptides, proteins, oligonucleotides, other biomolecules), application (therapeutics {antibody-drug conjugates (ADCs), peptide-drug conjugates, protein-drug conjugates, other therapeutic applications}, research & development, diagnostics), end user (pharmaceutical & biotechnology companies, CROs & CMOs, academic & research institutes, hospitals and clinical/diagnostic laboratories), service type ( custom synthesis & conjugation services, analytical & characterization services, scale-up & manufacturing services, other services), technique (chemical conjugation, click chemistry, enzyme-mediated conjugation, photoreactive crosslinking, other techniques), conjugation type (antibody conjugation, peptide conjugation, protein conjugation, oligonucleotide conjugation, other conjugation services), application (therapeutics, research & development, diagnostics), end user (pharmaceutical & biotechnology companies, academic & research institutes, hospitals and clinical/diagnostic laboratories), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the bioconjugation market. A thorough analysis of the key industry players has been done to provide insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. Also, it includes new product launches, collaborations and acquisitions, and recent developments associated with the bioconjugation market.
Reasons to buy this report
The report will help market leaders/new entrants by providing the closest approximations of the revenue numbers for the overall bioconjugation market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (growing demand for targeted therapies, increasing investments in biopharmaceutical R&D, rising demand for outsourcing services, expanding pipeline of bioconjugated drugs, advancements in bioconjugation technologies), restraints (high cost of bioconjugate development & manufacturing, stringent regulatory requirements), opportunities (high growth potential of emerging economies, expanding applications of bioconjugation), and Challenges (technical complexities) influencing the growth of the market.
- Product/Service Development/Innovation: Detailed insights on newly launched products/services of the bioconjugation market
- Market Development: Comprehensive information about lucrative markets – the report analyses the market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the bioconjugation market
Competitive Assessment: In-depth assessment of market shares, growth strategies and product/service offerings of leading players like Danaher Corporation (US), Lonza (Switzerland), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), AbbVie Inc. (US), WuXi Biologics (Cayman) Inc. (China), Sartorius AG (Germany), Bio-Rad Laboratories, Inc. (US), among others in the market.
Table of Contents
1 INTRODUCTION 58
1.1 STUDY OBJECTIVES 58
1.2 MARKET DEFINITION 58
1.3 MARKET SCOPE 58
1.3.1 MARKETS COVERED 59
1.3.2 INCLUSIONS & EXCLUSIONS 60
1.3.3 YEARS CONSIDERED 61
1.3.4 CURRENCY CONSIDERED 61
1.4 MARKET STAKEHOLDERS 61
2 RESEARCH METHODOLOGY 62
2.1 RESEARCH DATA 62
2.1.1 SECONDARY DATA 63
2.1.2 PRIMARY DATA 63
2.2 MARKET ESTIMATION METHODOLOGY 65
2.2.1 MARKET ESTIMATION 65
2.2.2 INSIGHTS FROM PRIMARY EXPERTS 68
2.2.3 TOP-DOWN APPROACH 68
2.3 MARKET GROWTH RATE PROJECTION 70
2.4 DATA TRIANGULATION 72
2.5 RESEARCH ASSUMPTIONS 73
2.6 RESEARCH LIMITATIONS 74
2.7 RISK ANALYSIS 74
3 EXECUTIVE SUMMARY 75
4 PREMIUM INSIGHTS 83
4.1 BIOCONJUGATION MARKET OVERVIEW 83
4.2 NORTH AMERICA: BIOCONJUGATION PRODUCTS MARKET, BY APPLICATION AND COUNTRY (2023) 84
4.3 BIOCONJUGATION PRODUCTS MARKET, BY TYPE (2023) 84
4.4 BIOCONJUGATION PRODUCTS MARKET, BY END USER (2023) 85
4.5 BIOCONJUGATION SERVICES MARKET, BY TYPE (2023) 85
4.6 BIOCONJUGATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 86
5 MARKET OVERVIEW 87
5.1 INTRODUCTION 87
5.2 MARKET DYNAMICS 88
5.2.1 DRIVERS 89
5.2.1.1 Growing demand for targeted therapies 89
5.2.1.2 Increasing investments in biopharmaceutical R&D 90
5.2.1.3 Rising demand for outsourcing services 91
5.2.1.4 Expanding pipeline of bioconjugate drugs 92
5.2.1.5 Advancements in bioconjugation technologies 93
5.2.2 RESTRAINTS 94
5.2.2.1 High cost of bioconjugate development & manufacturing 94
5.2.2.2 Stringent regulatory requirements 95
5.2.3 OPPORTUNITIES 95
5.2.3.1 High growth potential of emerging economies 95
5.2.3.2 Expanding applications of bioconjugation 96
5.2.4 CHALLENGES 96
5.2.4.1 Technical complexities 96
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 97
5.4 PRICING ANALYSIS 98
5.4.1 INDICATIVE PRODUCT PRICING ANALYSIS, BY KEY PLAYER 98
5.4.2 INDICATIVE PRODUCT PRICING ANALYSIS, BY REGION 99
5.5 SUPPLY CHAIN ANALYSIS 100
5.6 VALUE CHAIN ANALYSIS 102
5.7 ECOSYSTEM ANALYSIS 104
5.7.1 BIOCONJUGATION MARKET: RAW MATERIAL SUPPLIERS 104
5.7.2 BIOCONJUGATION MARKET: PRODUCT MANUFACTURERS 105
5.7.3 BIOCONJUGATION MARKET: SERVICE PROVIDERS 105
5.7.4 BIOCONJUGATION MARKET: END USERS 106
5.7.5 BIOCONJUGATION MARKET: REGULATORY BODIES 106
5.8 TECHNOLOGY ANALYSIS 107
5.8.1 KEY TECHNOLOGIES 107
5.8.1.1 Chemical conjugation 107
5.8.1.2 Enzymatic conjugation 107
5.8.1.3 Photochemical conjugation 108
5.8.1.4 Click chemistry 108
5.8.2 COMPLEMENTARY TECHNOLOGIES 108
5.8.3 ADJACENT TECHNOLOGIES 110
5.9 PATENT ANALYSIS 111
5.10 KEY CONFERENCES & EVENTS 113
5.11 REGULATORY LANDSCAPE 114
5.11.1 REGULATORY SCENARIO 114
5.11.1.1 North America 114
5.11.1.1.1 US 114
5.11.1.1.2 Canada 115
5.11.1.2 Europe 115
5.11.1.2.1 Germany 115
5.11.1.2.2 UK 115
5.11.1.3 Asia Pacific 115
5.11.1.3.1 Japan 115
5.11.1.3.2 China 115
5.11.1.4 Latin America 115
5.11.1.4.1 Brazil 115
5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 116
5.12 INVESTMENT & FUNDING SCENARIO 119
5.13 PORTER’S FIVE FORCES ANALYSIS 120
5.13.1 THREAT OF NEW ENTRANTS 121
5.13.2 THREAT OF SUBSTITUTES 121
5.13.3 BARGAINING POWER OF BUYERS 121
5.13.4 BARGAINING POWER OF SUPPLIERS 121
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 121
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 122
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 122
5.14.2 BUYING CRITERIA FOR END USERS 123
5.15 TRADE ANALYSIS 125
5.16 IMPACT OF AI/GENERATIVE AI ON BIOCONJUGATION MARKET 128
6 BIOCONJUGATION PRODUCTS MARKET, BY TYPE 130
6.1 INTRODUCTION 131
6.2 CONSUMABLES 131
6.2.1 REAGENTS & KITS 135
6.2.1.1 Linker and crosslinking reagents & kits 138
6.2.1.1.1 Precision in conjugation reactions to boost demand 138
6.2.1.2 Labeling reagents & kits 141
6.2.1.2.1 Growing demand for enhanced diagnostic sensitivity to fuel uptake 141
6.2.1.3 Modification reagents & kits 144
6.2.1.3.1 Uptake of protein engineering for optimal behavior to support market growth 144
6.2.1.4 Other reagents & kits 147
6.2.2 LABELS 150
6.2.2.1 Fluorescent tags 153
6.2.2.1.1 Rising demand in imaging & diagnostics to drive market 153
6.2.2.2 Enzymes 156
6.2.2.2.1 Increasing utilization of western blotting & ELISA kits to fuel market 156
6.2.2.3 Haptens 159
6.2.2.3.1 Wide applications in immunoassays and vaccine development to support market growth 159
6.2.2.4 Polymers 162
6.2.2.4.1 Advancements in polymer-based drug delivery systems to drive market 162
6.2.2.5 Bead coupling 165
6.2.2.5.1 Utilization in magnetic bead-based immunoassays and cell separation to support market growth 165
6.2.2.6 Other labels 168
6.2.3 OTHER CONSUMABLES 171
6.3 INSTRUMENTS 174
6.3.1 CHROMATOGRAPHY SYSTEMS 177
6.3.1.1 Ability to offer precision and purification to drive market 177
6.3.2 MASS SPECTROMETERS 180
6.3.2.1 High uptake in bioconjugate characterization to drive market 180
6.3.3 SPECTROSCOPY INSTRUMENTS 183
6.3.3.1 Monitoring of bioconjugation reactions in real-time to fuel uptake 183
6.3.4 FLOW CYTOMETERS 186
6.3.4.1 Determination of therapeutic potential in ADCs to propel market 186
6.3.5 ELECTROPHORESIS EQUIPMENT 189
6.3.5.1 Increasing requirement for reliable analysis to support market growth 189
6.3.6 FILTRATION SYSTEMS 192
6.3.6.1 High purity requirements to support market growth 192
6.3.7 MIXERS & SHAKERS 195
6.3.7.1 Ability to ensure uniform conjugation reactions to boost demand 195
6.3.8 INCUBATORS 197
6.3.8.1 Integration of smart technologies for controlled environments to drive market 197
6.3.9 OTHER INSTRUMENTS 200
7 BIOCONJUGATION PRODUCTS MARKET, BY TECHNIQUE 203
7.1 INTRODUCTION 204
7.2 CHEMICAL CONJUGATION 204
7.2.1 HIGH DEMAND FOR ONCOLOGY ADCS AND VERSATILE TECHNIQUE TO PROPEL MARKET 204
7.3 CLICK CHEMISTRY 208
7.3.1 GROWING NEED FOR REGULATORY COMPLIANCE AND QUALITY ASSURANCE TO PROPEL MARKET 208
7.4 ENZYME-MEDIATED CONJUGATION 211
7.4.1 INCREASING NUMBER OF CLINICAL TRIALS TO BOOST DEMAND 211
7.5 PHOTOREACTIVE CROSSLINKING 214
7.5.1 DEVELOPMENT OF LIGHT-ACTIVATED THERAPEUTICS AND IMAGING AGENTS TO SUPPORT MARKET GROWTH 214
7.6 OTHER TECHNIQUES 217
8 BIOCONJUGATION PRODUCTS MARKET, BY BIOMOLECULE TYPE 221
8.1 INTRODUCTION 222
8.2 ANTIBODIES 222
8.2.1 EXPANDING THERAPEUTIC APPLICATIONS TO SUPPORT MARKET GROWTH 222
8.3 PEPTIDES 225
8.3.1 HIGH FLEXIBILITY AND DRUG DELIVERY EFFICIENCY TO FUEL UPTAKE 225
8.4 PROTEINS 228
8.4.1 INCREASING DEVELOPMENT OF ELISA AND PDCS IN THERAPEUTIC APPLICATIONS TO DRIVE MARKET 228
8.5 OLIGONUCLEOTIDES 231
8.5.1 GROWING UPTAKE IN GENE THERAPY TO SUPPORT MARKET 231
8.6 OTHER BIOMOLECULES 234
9 BIOCONJUGATION PRODUCTS MARKET, BY APPLICATION 237
9.1 INTRODUCTION 238
9.2 THERAPEUTICS 238
9.2.1 ANTIBODY-DRUG CONJUGATES 243
9.2.1.1 Increasing demand for targeted cancer therapies to propel market 243
9.2.2 PEPTIDE-DRUG CONJUGATES 246
9.2.2.1 Advancements in peptide synthesis to boost demand 246
9.2.3 PROTEIN-DRUG CONJUGATES 250
9.2.3.1 Improvements in bioavailability and pharmacokinetics of therapeutic agents to drive market 250
9.2.4 OTHER THERAPEUTIC APPLICATIONS 253
9.3 RESEARCH & DEVELOPMENT 256
9.3.1 GROWING INTEREST IN INNOVATIVE THERAPEUTIC MODALITIES TO DRIVE MARKET 256
9.4 DIAGNOSTICS 259
9.4.1 UTILIZATION IN DIAGNOSTIC ASSAY DEVELOPMENT TO SUPPORT MARKET GROWTH 259
10 BIOCONJUGATION PRODUCTS MARKET, BY END USER 263
10.1 INTRODUCTION 264
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 264
10.2.1 INCREASING ADOPTION OF BIOCONJUGATION IN TARGETED THERAPIES TO DRIVE MARKET 264
10.3 CONTRACT RESEARCH ORGANIZATIONS (CROS) & CONTRACT MANUFACTURING ORGANIZATIONS (CMOS) 268
10.3.1 INCREASING OUTSOURCING OF BIOCONJUGATION SERVICES TO PROPEL MARKET 268
10.4 ACADEMIC & RESEARCH INSTITUTES 271
10.4.1 INCREASING FOCUS ON NOVEL BIOCONJUGATION TECHNIQUES FOR BASIC & APPLIED RESEARCH TO FUEL UPTAKE 271
10.5 HOSPITALS AND CLINICAL/DIAGNOSTIC LABORATORIES 274
10.5.1 EXPANDING APPLICATIONS OF BIOCONJUGATES IN DIAGNOSTICS & THERAPEUTICS TO SUPPORT MARKET GROWTH 274
11 BIOCONJUGATION SERVICES MARKET, BY TYPE 278
11.1 INTRODUCTION 279
11.2 CUSTOM SYNTHESIS & CONJUGATION SERVICES 279
11.2.1 GROWING NEED FOR TARGETED & CUSTOMIZED THERAPIES TO DRIVE MARKET 279
11.3 ANALYTICAL & CHARACTERIZATION SERVICES 283
11.3.1 GROWING FOCUS ON REGULATORY COMPLIANCE TO FUEL UPTAKE 283
11.4 SCALE-UP & MANUFACTURING SERVICES 286
11.4.1 INCREASING COMMERCIALIZATION OF BIOCONJUGATED DRUGS TO SUPPORT MARKET GROWTH 286
11.5 OTHER SERVICES 289
12 BIOCONJUGATION SERVICES MARKET, BY CONJUGATION TYPE 292
12.1 INTRODUCTION 293
12.2 ANTIBODY CONJUGATION 293
12.2.1 ABILITY TO LINK ANTIBODIES TO PAYLOADS FOR SPECIALIZED THERAPEUTICS TO PROPEL MARKET 293
12.3 PEPTIDE CONJUGATION 297
12.3.1 IMPROVED STABILITY & BIOAVAILABILITY TO DRIVE MARKET 297
12.4 PROTEIN CONJUGATION 300
12.4.1 LINKING PROTEINS WITH DRUGS FOR TARGETED DELIVERY TO FUEL UPTAKE 300
12.5 OLIGONUCLEOTIDE CONJUGATION 304
12.5.1 ADVANCEMENTS IN NUCLEIC ACID-BASED THERAPEUTICS TO SUPPORT MARKET GROWTH 304
12.6 OTHER CONJUGATION SERVICES 307
13 BIOCONJUGATION SERVICES MARKET, BY TECHNIQUE 311
13.1 INTRODUCTION 312
13.2 CHEMICAL CONJUGATION 312
13.2.1 ESSENTIAL TECHNIQUE FOR DEVELOPMENT OF CUSTOM BIOCONJUGATES TO FUEL UPTAKE 312
13.3 CLICK CHEMISTRY 316
13.3.1 PROVISION OF HIGH YIELD FOR DEVELOPMENT OF COMPLEX BIOCONJUGATES TO PROPEL MARKET 316
13.4 ENZYME-MEDIATED CONJUGATION 319
13.4.1 NEED FOR PRECISE & STABLE CONJUGATES IN COMPLEX THERAPEUTIC MODALITIES TO DRIVE MARKET 319
13.5 PHOTOREACTIVE CROSSLINKING 322
13.5.1 ABILITY TO PROVIDE CONTROLLED & SITE-SPECIFIC FORMATION OF CROSSLINKS TO SUPPORT MARKET GROWTH 322
13.6 OTHER TECHNIQUES 325
14 BIOCONJUGATION SERVICES MARKET, BY APPLICATION 328
14.1 INTRODUCTION 329
14.2 THERAPEUTICS 329
14.2.1 STRATEGIC PARTNERSHIPS BETWEEN BIOPHARMA COMPANIES AND BIOCONJUGATION SERVICE PROVIDERS TO PROPEL MARKET 329
14.3 RESEARCH & DEVELOPMENT 333
14.3.1 GROWING FOCUS ON BIOMOLECULAR RESEARCH INNOVATION TO DRIVE MARKET 333
14.4 DIAGNOSTICS 336
14.4.1 DEVELOPMENT OF ADVANCED IMAGING TECHNOLOGIES AND BIOSENSORS TO SUPPORT MARKET GROWTH 336
15 BIOCONJUGATION SERVICES MARKET, BY END USER 340
15.1 INTRODUCTION 341
15.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 341
15.2.1 ADVANCEMENTS IN DRUG DISCOVERY & DEVELOPMENT TO PROPEL MARKET 341
15.3 ACADEMIC & RESEARCH INSTITUTES 345
15.3.1 INNOVATION IN CONJUGATION TECHNIQUES AND BIOMEDICAL RESEARCH TO DRIVE MARKET 345
15.4 HOSPITALS AND CLINICAL/DIAGNOSTIC LABORATORIES 348
15.4.1 INCREASING DEMAND FOR PRECISION DIAGNOSTICS TO FUEL UPTAKE 348
16 BIOCONJUGATION MARKET, BY REGION 351
16.1 INTRODUCTION 352
16.2 NORTH AMERICA 353
16.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK 362
16.2.2 US 362
16.2.2.1 High healthcare expenditure to propel market 362
16.2.3 CANADA 369
16.2.3.1 Increasing government funding for drug development to support market growth 369
16.3 EUROPE 376
16.3.1 EUROPE: MACROECONOMIC OUTLOOK 383
16.3.2 GERMANY 384
16.3.2.1 Facility expansion by key players to aid market growth 384
16.3.3 UK 391
16.3.3.1 Increased cancer prevalence and government funding for pharmaceutical & biotechnology research to fuel uptake 391
16.3.4 FRANCE 397
16.3.4.1 Favorable government initiatives and growing demand for personalized therapeutics to boost demand 397
16.3.5 ITALY 403
16.3.5.1 Increasing industrial collaborations for ADC production to support market growth 403
16.3.6 SPAIN 409
16.3.6.1 Growing preference for personalized medicine to drive market 409
16.3.7 REST OF EUROPE 415
16.4 ASIA PACIFIC 422
16.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK 430
16.4.2 CHINA 431
16.4.2.1 Expansion of biopharmaceutical manufacturing facilities to boost demand 431
16.4.3 JAPAN 438
16.4.3.1 Increasing collaborations among biotechnology companies to support market growth 438
16.4.4 INDIA 445
16.4.4.1 High investments in pharma R&D and favorable government policies to boost demand 445
16.4.5 SOUTH KOREA 451
16.4.5.1 Increased focus on quality manufacturing practices to propel market 451
16.4.6 AUSTRALIA 458
16.4.6.1 Growing demand for innovative research solutions to drive market 458
16.4.7 REST OF ASIA PACIFIC 464
16.5 LATIN AMERICA 471
16.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK 478
16.5.2 BRAZIL 479
16.5.2.1 Increasing pharmaceutical R&D to fuel market 479
16.5.3 MEXICO 486
16.5.3.1 High FDIs and reduced pharmaceutical manufacturing costs to drive market 486
16.5.4 REST OF LATIN AMERICA 492
16.6 MIDDLE EAST 499
16.6.1 MIDDLE EAST: MACROECONOMIC OUTLOOK 506
16.6.2 GCC COUNTRIES 507
16.6.2.1 Kingdom of Saudi Arabia 514
16.6.2.1.1 Rising healthcare expenditure to boost market 514
16.6.2.2 United Arab Emirates 521
16.6.2.2.1 Increasing collaborations among biopharma companies to aid market growth 521
16.6.2.3 Other GCC Countries 527
16.6.3 REST OF MIDDLE EAST 534
16.7 AFRICA 541
16.7.1 INCREASING TARGET PATIENT POOL TO SUPPORT MARKET GROWTH 541
16.7.2 AFRICA: MACROECONOMIC OUTLOOK 547
17 COMPETITIVE LANDSCAPE 549
17.1 OVERVIEW 549
17.2 KEY PLAYER STRATEGY/RIGHT TO WIN 549
17.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN BIOCONJUGATION MARKET 550
17.3 REVENUE ANALYSIS 551
17.4 MARKET SHARE ANALYSIS 552
17.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 554
17.5.1 STARS 554
17.5.2 EMERGING LEADERS 554
17.5.3 PERVASIVE PLAYERS 554
17.5.4 PARTICIPANTS 555
17.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 556
17.5.5.1 Company footprint 556
17.5.5.2 Product/Service footprint 557
17.5.5.3 Application footprint 558
17.5.5.4 End-user footprint 559
17.5.5.5 Region footprint 560
17.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 562
17.6.1 PROGRESSIVE COMPANIES 562
17.6.2 RESPONSIVE COMPANIES 562
17.6.3 DYNAMIC COMPANIES 562
17.6.4 STARTING BLOCKS 562
17.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 564
17.7 COMPANY VALUATION & FINANCIAL METRICS 566
17.7.1 FINANCIAL METRICS 566
17.7.2 COMPANY VALUATION 567
17.8 BRAND/PRODUCT/SERVICE COMPARISON 568
17.9 COMPETITIVE SCENARIO 569
17.9.1 PRODUCT/SERVICE LAUNCHES 569
17.9.2 DEALS 570
17.9.3 EXPANSIONS 571
18 COMPANY PROFILES 573
18.1 KEY PLAYERS 573
18.1.1 DANAHER CORPORATION 573
18.1.1.1 Business overview 573
18.1.1.2 Products/Services offered 574
18.1.1.3 Recent developments 582
18.1.1.3.1 Product/Service launches 582
18.1.1.3.2 Deals 583
18.1.1.3.3 Expansions 583
18.1.1.4 MnM view 584
18.1.1.4.1 Key strengths 584
18.1.1.4.2 Strategic choices 584
18.1.1.4.3 Weaknesses & competitive threats 585
18.1.2 LONZA 586
18.1.2.1 Business overview 586
18.1.2.2 Products/Services offered 587
18.1.2.3 Recent developments 588
18.1.2.3.1 Deals 588
18.1.2.3.2 Expansions 588
18.1.2.4 MnM view 589
18.1.2.4.1 Key strengths 589
18.1.2.4.2 Strategic choices 589
18.1.2.4.3 Weaknesses & competitive threats 589
18.1.3 THERMO FISHER SCIENTIFIC INC. 590
18.1.3.1 Business overview 590
18.1.3.2 Products/Services offered 591
18.1.3.3 Recent developments 597
18.1.3.3.1 Product/Service launches 597
18.1.3.3.2 Deals 598
18.1.3.3.3 Expansions 598
18.1.3.4 MnM view 599
18.1.3.4.1 Key strengths 599
18.1.3.4.2 Strategic choices 599
18.1.3.4.3 Weaknesses & competitive threats 600
18.1.4 MERCK KGAA 601
18.1.4.1 Business overview 601
18.1.4.2 Products/Services offered 602
18.1.4.3 Recent developments 606
18.1.4.3.1 Product/Service launches 606
18.1.4.3.2 Deals 607
18.1.4.3.3 Expansions 607
18.1.4.4 MnM view 609
18.1.4.4.1 Key strengths 609
18.1.4.4.2 Strategic choices 609
18.1.4.4.3 Weaknesses & competitive threats 609
18.1.5 ABBVIE INC. 610
18.1.5.1 Business overview 610
18.1.5.2 Products/Services offered 611
18.1.5.3 Recent developments 611
18.1.5.3.1 Deals 611
18.1.5.3.2 Expansions 612
18.1.5.4 MnM view 612
18.1.5.4.1 Key strengths 612
18.1.5.4.2 Strategic choices 612
18.1.5.4.3 Weaknesses & competitive threats 612
18.1.6 WUXI BIOLOGICS (CAYMAN) INC. 613
18.1.6.1 Business overview 613
18.1.6.2 Products/Services offered 614
18.1.6.3 Recent developments 615
18.1.6.3.1 Deals 615
18.1.6.3.2 Expansions 616
18.1.7 SARTORIUS AG 617
18.1.7.1 Business overview 617
18.1.7.2 Products/Services offered 618
18.1.7.3 Recent developments 620
18.1.7.3.1 Deals 620
18.1.7.3.2 Expansions 621
18.1.8 BIO-RAD LABORATORIES, INC. 623
18.1.8.1 Business overview 623
18.1.8.2 Products/Services offered 624
18.1.9 CATALENT, INC. 628
18.1.9.1 Business overview 628
18.1.9.2 Products/Services offered 629
18.1.9.3 Recent developments 630
18.1.9.3.1 Product/Service launches 630
18.1.9.3.2 Deals 630
18.1.9.3.3 Expansions 631
18.1.10 BECKTON, DICKINSON AND COMPANY 632
18.1.10.1 Business overview 632
18.1.10.2 Products/Services offered 633
18.1.10.3 Recent developments 635
18.1.10.3.1 Product/Service launches 635
18.1.10.3.2 Deals 635
18.1.11 AGILENT TECHNOLOGIES, INC. 636
18.1.11.1 Business overview 636
18.1.11.2 Products/Services offered 637
18.1.11.3 Recent developments 638
18.1.11.3.1 Product/Service launches 638
18.1.11.3.2 Deals 639
18.1.11.3.3 Expansions 640
18.1.12 PROMEGA CORPORATION 641
18.1.12.1 Business overview 641
18.1.12.2 Products/Services offered 641
18.1.13 F. HOFFMANN-LA ROCHE LTD. 642
18.1.13.1 Business overview 642
18.1.13.2 Products/Services offered 643
18.1.14 CHARLES RIVER LABORATORIES 645
18.1.14.1 Business overview 645
18.1.14.2 Products/Services offered 646
18.1.14.3 Recent developments 647
18.1.14.3.1 Deals 647
18.1.15 GENSCRIPT BIOTECH CORPORATION 648
18.1.15.1 Business overview 648
18.1.15.2 Products/Services offered 649
18.1.15.3 Recent developments 650
18.1.15.3.1 Deals 650
18.1.16 PIRAMAL PHARMA LIMITED 651
18.1.16.1 Business overview 651
18.1.16.2 Products/services offered 652
18.1.16.3 Recent developments 653
18.1.16.3.1 Product/Service launches 653
18.1.16.3.2 Expansions 653
18.2 OTHER PLAYERS 654
18.2.1 ABZENA LTD. 654
18.2.2 NEW ENGLAND BIOLABS 655
18.2.3 BIOSYNTH 656
18.2.4 CELL SIGNALING TECHNOLOGY, INC. 657
18.2.5 CREATIVE BIOLABS 658
18.2.6 FORMOSA LABORATORIES INC. 659
18.2.7 NJ BIO, INC. 660
18.2.8 ROCKLAND IMMUNOCHEMICALS, INC. 661
18.2.9 SHANGHAI CHEMPARTNER 662
18.2.10 STERLING PHARMA SOLUTIONS LIMITED 662
18.2.11 SYNGENE INTERNATIONAL LIMITED 663
18.2.12 TOKYO CHEMICAL INDUSTRY CO., LTD. 664
18.2.13 VECTOR LABORATORIES, INC. 665
19 APPENDIX 666
19.1 DISCUSSION GUIDE 666
19.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 672
19.3 CUSTOMIZATION OPTIONS 674
19.4 RELATED REPORTS 675
19.5 AUTHOR DETAILS 676
LIST OF TABLES
TABLE 1 BIOCONJUGATION MARKET: INCLUSIONS & EXCLUSIONS 60
TABLE 2 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 71
TABLE 3 BIOCONJUGATION MARKET: RISK ASSESSMENT ANALYSIS 74
TABLE 4 BIOCONJUGATION MARKET: IMPACT ANALYSIS 88
TABLE 5 LIST OF KEY SITE-SPECIFIC CONJUGATION TECHNOLOGIES (ENGINEERED REACTIVE CYSTEINES/ CYSTEINE CONJUGATION) 93
TABLE 6 INDICATIVE PRODUCT PRICING ANALYSIS, BY KEY PLAYER (2023) 98
TABLE 7 INDICATIVE PRICING ANALYSIS OF BIOCONJUGATION PRODUCTS, BY REGION (2023) 99
TABLE 8 BIOCONJUGATION MARKET: RAW MATERIAL SUPPLIERS 104
TABLE 9 BIOCONJUGATION MARKET: PRODUCT MANUFACTURERS 105
TABLE 10 BIOCONJUGATION MARKET: SERVICE PROVIDERS 105
TABLE 11 BIOCONJUGATION MARKET: END USERS 106
TABLE 12 BIOCONJUGATION MARKET: REGULATORY BODIES 107
TABLE 13 BIOCONJUGATION: COMPLEMENTARY TECHNOLOGIES 109
TABLE 14 BIOCONJUGATION: ADJACENT TECHNOLOGIES 110
TABLE 15 KEY PATENTS IN BIOCONJUGATION MARKET 112
TABLE 16 BIOCONJUGATION MARKET: KEY CONFERENCES & EVENTS, 2024–2025 113
TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 116
TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 116
TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 117
TABLE 20 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 118
TABLE 21 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 118
TABLE 22 LIST OF ANTIBODY-DRUG CONJUGATE VENTURE CAPITAL FUNDING EVENTS
AND IPOS. 119
TABLE 23 BIOCONJUGATION MARKET: PORTER’S FIVE FORCES ANALYSIS 120
TABLE 24 KEY BUYING CRITERIA FOR BIOCONJUGATION PRODUCTS, BY END USER 123
TABLE 25 IMPORT VALUE FOR HS CODE 9027, 2019–2023 (USD THOUSAND) 125
TABLE 26 EXPORT VALUE FOR HS CODE 9027, 2019–2023 (USD THOUSAND) 126
TABLE 27 IMPORT VOLUME FOR HS CODE 9027, 2019–2023 (TONS) 126
TABLE 28 EXPORT VOLUME FOR HS CODE 9027, 2019–2023 (TONS) 127
TABLE 29 BIOCONJUGATION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 131
TABLE 30 BIOCONJUGATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 132
TABLE 31 BIOCONJUGATION CONSUMABLES MARKET, BY REGION,
2022–2029 (USD MILLION) 132
TABLE 32 NORTH AMERICA: BIOCONJUGATION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 132
TABLE 33 EUROPE: BIOCONJUGATION CONSUMABLES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 133
TABLE 34 ASIA PACIFIC: BIOCONJUGATION CONSUMABLES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 133
TABLE 35 LATIN AMERICA: BIOCONJUGATION CONSUMABLES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 134
TABLE 36 MIDDLE EAST: BIOCONJUGATION CONSUMABLES MARKET, BY REGION,
2022–2029 (USD MILLION) 134
TABLE 37 GCC COUNTRIES: BIOCONJUGATION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 134
TABLE 38 BIOCONJUGATION REAGENTS & KITS MARKET, BY TYPE,
2022–2029 (USD MILLION) 135
TABLE 39 BIOCONJUGATION REAGENTS & KITS MARKET, BY REGION,
2022–2029 (USD MILLION) 136
TABLE 40 NORTH AMERICA: BIOCONJUGATION REAGENTS & KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 136
TABLE 41 EUROPE: BIOCONJUGATION REAGENTS & KITS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 136
TABLE 42 ASIA PACIFIC: BIOCONJUGATION REAGENTS & KITS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 137
TABLE 43 LATIN AMERICA: BIOCONJUGATION REAGENTS & KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 137
TABLE 44 MIDDLE EAST: BIOCONJUGATION REAGENTS & KITS MARKET, BY REGION,
2022–2029 (USD MILLION) 137
TABLE 45 GCC COUNTRIES: BIOCONJUGATION REAGENTS & KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 138
TABLE 46 BIOCONJUGATION LINKER AND CROSSLINKING REAGENTS & KITS MARKET,
BY REGION, 2022–2029 (USD MILLION) 139
TABLE 47 NORTH AMERICA: BIOCONJUGATION LINKER AND CROSSLINKING REAGENTS & KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 139
TABLE 48 EUROPE: BIOCONJUGATION LINKER AND CROSSLINKING REAGENTS & KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 139
TABLE 49 ASIA PACIFIC: BIOCONJUGATION LINKER AND CROSSLINKING REAGENTS & KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 140
TABLE 50 LATIN AMERICA: BIOCONJUGATION LINKER AND CROSSLINKING REAGENTS & KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 140
TABLE 51 MIDDLE EAST: BIOCONJUGATION LINKER AND CROSSLINKING REAGENTS & KITS MARKET, BY REGION, 2022–2029 (USD MILLION) 140
TABLE 52 GCC COUNTRIES: BIOCONJUGATION LINKER AND CROSSLINKING REAGENTS & KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 141
TABLE 53 BIOCONJUGATION LABELING REAGENTS & KITS MARKET, BY REGION,
2022–2029 (USD MILLION) 142
TABLE 54 NORTH AMERICA: BIOCONJUGATION LABELING REAGENTS & KITS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 142
TABLE 55 EUROPE: BIOCONJUGATION LABELING REAGENTS & KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 142
TABLE 56 ASIA PACIFIC: BIOCONJUGATION LABELING REAGENTS & KITS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 143
TABLE 57 LATIN AMERICA: BIOCONJUGATION LABELING REAGENTS & KITS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 143
TABLE 58 MIDDLE EAST: BIOCONJUGATION LABELING REAGENTS & KITS MARKET,
BY REGION, 2022–2029 (USD MILLION) 143
TABLE 59 GCC COUNTRIES: BIOCONJUGATION LABELING REAGENTS & KITS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 144
TABLE 60 BIOCONJUGATION MODIFICATION REAGENTS & KITS MARKET, BY REGION,
2022–2029 (USD MILLION) 145
TABLE 61 NORTH AMERICA: BIOCONJUGATION MODIFICATION REAGENTS & KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 145
TABLE 62 EUROPE: BIOCONJUGATION MODIFICATION REAGENTS & KITS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 145
TABLE 63 ASIA PACIFIC: BIOCONJUGATION MODIFICATION REAGENTS & KITS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 146
TABLE 64 LATIN AMERICA: BIOCONJUGATION MODIFICATION REAGENTS & KITS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 146
TABLE 65 MIDDLE EAST: BIOCONJUGATION MODIFICATION REAGENTS & KITS MARKET,
BY REGION, 2022–2029 (USD MILLION) 146
TABLE 66 GCC COUNTRIES: BIOCONJUGATION MODIFICATION REAGENTS & KITS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 147
TABLE 67 OTHER BIOCONJUGATION REAGENTS & KITS MARKET, BY REGION,
2022–2029 (USD MILLION) 147
TABLE 68 NORTH AMERICA: OTHER BIOCONJUGATION REAGENTS & KITS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 148
TABLE 69 EUROPE: OTHER BIOCONJUGATION REAGENTS & KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 148
TABLE 70 ASIA PACIFIC: OTHER BIOCONJUGATION REAGENTS & KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 148
TABLE 71 LATIN AMERICA: OTHER BIOCONJUGATION REAGENTS & KITS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 149
TABLE 72 MIDDLE EAST: OTHER BIOCONJUGATION REAGENTS & KITS MARKET, BY REGION, 2022–2029 (USD MILLION) 149
TABLE 73 GCC COUNTRIES: OTHER BIOCONJUGATION REAGENTS & KITS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 149
TABLE 74 BIOCONJUGATION LABELS MARKET, BY TYPE, 2022–2029 (USD MILLION) 150
TABLE 75 BIOCONJUGATION LABELS MARKET, BY REGION, 2022–2029 (USD MILLION) 150
TABLE 76 NORTH AMERICA: BIOCONJUGATION LABELS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 151
TABLE 77 EUROPE: BIOCONJUGATION LABELS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 151
TABLE 78 ASIA PACIFIC: BIOCONJUGATION LABELS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 151
TABLE 79 LATIN AMERICA: BIOCONJUGATION LABELS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 152
TABLE 80 MIDDLE EAST: BIOCONJUGATION LABELS MARKET, BY REGION,
2022–2029 (USD MILLION) 152
TABLE 81 GCC COUNTRIES: BIOCONJUGATION LABELS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 152
TABLE 82 BIOCONJUGATION LABELS MARKET FOR FLUORESCENT TAGS, BY REGION,
2022–2029 (USD MILLION) 153
TABLE 83 NORTH AMERICA: BIOCONJUGATION LABELS MARKET FOR FLUORESCENT TAGS, BY COUNTRY, 2022–2029 (USD MILLION) 153
TABLE 84 EUROPE: BIOCONJUGATION LABELS MARKET FOR FLUORESCENT TAGS,
BY COUNTRY, 2022–2029 (USD MILLION) 154
TABLE 85 ASIA PACIFIC: BIOCONJUGATION LABELS MARKET FOR FLUORESCENT TAGS,
BY COUNTRY, 2022–2029 (USD MILLION) 154
TABLE 86 LATIN AMERICA: BIOCONJUGATION LABELS MARKET FOR FLUORESCENT TAGS,
BY COUNTRY, 2022–2029 (USD MILLION) 155
TABLE 87 MIDDLE EAST: BIOCONJUGATION LABELS MARKET FOR FLUORESCENT TAGS,
BY REGION, 2022–2029 (USD MILLION) 155
TABLE 88 GCC COUNTRIES: BIOCONJUGATION LABELS MARKET FOR FLUORESCENT TAGS,
BY COUNTRY, 2022–2029 (USD MILLION) 155
TABLE 89 BIOCONJUGATION LABELS MARKET FOR ENZYMES, BY REGION,
2022–2029 (USD MILLION) 156
TABLE 90 NORTH AMERICA: BIOCONJUGATION LABELS MARKET FOR ENZYMES,
BY COUNTRY, 2022–2029 (USD MILLION) 157
TABLE 91 EUROPE: BIOCONJUGATION LABELS MARKET FOR ENZYMES, BY COUNTRY,
2022–2029 (USD MILLION) 157
TABLE 92 ASIA PACIFIC: BIOCONJUGATION LABELS MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION) 157
TABLE 93 LATIN AMERICA: BIOCONJUGATION LABELS MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION) 158
TABLE 94 MIDDLE EAST: BIOCONJUGATION LABELS MARKET FOR ENZYMES, BY REGION, 2022–2029 (USD MILLION) 158
TABLE 95 GCC COUNTRIES: BIOCONJUGATION LABELS MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION) 158
TABLE 96 BIOCONJUGATION LABELS MARKET FOR HAPTENS, BY REGION,
2022–2029 (USD MILLION) 159
TABLE 97 NORTH AMERICA: BIOCONJUGATION LABELS MARKET FOR HAPTENS, BY COUNTRY, 2022–2029 (USD MILLION) 160
TABLE 98 EUROPE: BIOCONJUGATION LABELS MARKET FOR HAPTENS, BY COUNTRY,
2022–2029 (USD MILLION) 160
TABLE 99 ASIA PACIFIC: BIOCONJUGATION LABELS MARKET FOR HAPTENS, BY COUNTRY, 2022–2029 (USD MILLION) 160
TABLE 100 LATIN AMERICA: BIOCONJUGATION LABELS MARKET FOR HAPTENS, BY COUNTRY, 2022–2029 (USD MILLION) 161
TABLE 101 MIDDLE EAST: BIOCONJUGATION LABELS MARKET FOR HAPTENS, BY REGION, 2022–2029 (USD MILLION) 161
TABLE 102 GCC COUNTRIES: BIOCONJUGATION LABELS MARKET FOR HAPTENS, BY COUNTRY, 2022–2029 (USD MILLION) 161
TABLE 103 BIOCONJUGATION LABELS MARKET FOR POLYMERS, BY REGION,
2022–2029 (USD MILLION) 162
TABLE 104 NORTH AMERICA: BIOCONJUGATION LABELS MARKET FOR POLYMERS,
BY COUNTRY, 2022–2029 (USD MILLION) 162
TABLE 105 EUROPE: BIOCONJUGATION LABELS MARKET FOR POLYMERS, BY COUNTRY, 2022–2029 (USD MILLION) 163
TABLE 106 ASIA PACIFIC: BIOCONJUGATION LABELS MARKET FOR POLYMERS, BY COUNTRY, 2022–2029 (USD MILLION) 163
TABLE 107 LATIN AMERICA: BIOCONJUGATION LABELS MARKET FOR POLYMERS,
BY COUNTRY, 2022–2029 (USD MILLION) 164
TABLE 108 MIDDLE EAST: BIOCONJUGATION LABELS MARKET FOR POLYMERS, BY REGION, 2022–2029 (USD MILLION) 164
TABLE 109 GCC COUNTRIES: BIOCONJUGATION LABELS MARKET FOR POLYMERS,
BY COUNTRY, 2022–2029 (USD MILLION) 164
TABLE 110 BIOCONJUGATION LABELS MARKET FOR BEAD COUPLING, BY REGION,
2022–2029 (USD MILLION) 165
TABLE 111 NORTH AMERICA: BIOCONJUGATION LABELS MARKET FOR BEAD COUPLING,
BY COUNTRY, 2022–2029 (USD MILLION) 165
TABLE 112 EUROPE: BIOCONJUGATION LABELS MARKET FOR BEAD COUPLING, BY COUNTRY, 2022–2029 (USD MILLION) 166
TABLE 113 ASIA PACIFIC: BIOCONJUGATION LABELS MARKET FOR BEAD COUPLING,
BY COUNTRY, 2022–2029 (USD MILLION) 166
TABLE 114 LATIN AMERICA: BIOCONJUGATION LABELS MARKET FOR BEAD COUPLING,
BY COUNTRY, 2022–2029 (USD MILLION) 167
TABLE 115 MIDDLE EAST: BIOCONJUGATION LABELS MARKET FOR BEAD COUPLING,
BY REGION, 2022–2029 (USD MILLION) 167
TABLE 116 GCC COUNTRIES: BIOCONJUGATION LABELS MARKET FOR BEAD COUPLING,
BY COUNTRY, 2022–2029 (USD MILLION) 167
TABLE 117 OTHER BIOCONJUGATION LABELS MARKET, BY REGION,
2022–2029 (USD MILLION) 168
TABLE 118 NORTH AMERICA: OTHER BIOCONJUGATION LABELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 169
TABLE 119 EUROPE: OTHER BIOCONJUGATION LABELS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 169
TABLE 120 ASIA PACIFIC: OTHER BIOCONJUGATION LABELS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 169
TABLE 121 LATIN AMERICA: OTHER BIOCONJUGATION LABELS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 170
TABLE 122 MIDDLE EAST: OTHER BIOCONJUGATION LABELS MARKET, BY REGION,
2022–2029 (USD MILLION) 170
TABLE 123 GCC COUNTRIES: OTHER BIOCONJUGATION LABELS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 170
TABLE 124 OTHER BIOCONJUGATION CONSUMABLES MARKET, BY REGION,
2022–2029 (USD MILLION) 171
TABLE 125 NORTH AMERICA: OTHER BIOCONJUGATION CONSUMABLES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 171
TABLE 126 EUROPE: OTHER BIOCONJUGATION CONSUMABLES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 172
TABLE 127 ASIA PACIFIC: OTHER BIOCONJUGATION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 172
TABLE 128 LATIN AMERICA: OTHER BIOCONJUGATION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 173
TABLE 129 MIDDLE EAST: OTHER BIOCONJUGATION CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION) 173
TABLE 130 GCC COUNTRIES: OTHER BIOCONJUGATION CONSUMABLES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 173
TABLE 131 BIOCONJUGATION INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 174
TABLE 132 BIOCONJUGATION INSTRUMENTS MARKET, BY REGION,
2022–2029 (USD MILLION) 175
TABLE 133 NORTH AMERICA: BIOCONJUGATION INSTRUMENTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 175
TABLE 134 EUROPE: BIOCONJUGATION INSTRUMENTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 175
TABLE 135 ASIA PACIFIC: BIOCONJUGATION INSTRUMENTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 176
TABLE 136 LATIN AMERICA: BIOCONJUGATION INSTRUMENTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 176
TABLE 137 MIDDLE EAST: BIOCONJUGATION INSTRUMENTS MARKET, BY REGION,
2022–2029 (USD MILLION) 176
TABLE 138 GCC COUNTRIES: BIOCONJUGATION INSTRUMENTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 177
TABLE 139 CHROMATOGRAPHY SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 178
TABLE 140 NORTH AMERICA: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 178
TABLE 141 EUROPE: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 178
TABLE 142 ASIA PACIFIC: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 179
TABLE 143 LATIN AMERICA: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 179
TABLE 144 MIDDLE EAST: CHROMATOGRAPHY SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION) 179
TABLE 145 GCC COUNTRIES: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 180
TABLE 146 MASS SPECTROMETERS MARKET, BY REGION, 2022–2029 (USD MILLION) 181
TABLE 147 NORTH AMERICA: MASS SPECTROMETERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 181
TABLE 148 EUROPE: MASS SPECTROMETERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 181
TABLE 149 ASIA PACIFIC: MASS SPECTROMETERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 182
TABLE 150 LATIN AMERICA: MASS SPECTROMETERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 182
TABLE 151 MIDDLE EAST: MASS SPECTROMETERS MARKET, BY REGION,
2022–2029 (USD MILLION) 182
TABLE 152 GCC COUNTRIES: MASS SPECTROMETERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 183
TABLE 153 SPECTROSCOPY INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 183
TABLE 154 NORTH AMERICA: SPECTROSCOPY INSTRUMENTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 184
TABLE 155 EUROPE: SPECTROSCOPY INSTRUMENTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 184
TABLE 156 ASIA PACIFIC: SPECTROSCOPY INSTRUMENTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 184
TABLE 157 LATIN AMERICA: SPECTROSCOPY INSTRUMENTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 185
TABLE 158 MIDDLE EAST: SPECTROSCOPY INSTRUMENTS MARKET, BY REGION,
2022–2029 (USD MILLION) 185
TABLE 159 GCC COUNTRIES: SPECTROSCOPY INSTRUMENTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 185
TABLE 160 FLOW CYTOMETERS MARKET, BY REGION, 2022–2029 (USD MILLION) 186
TABLE 161 NORTH AMERICA: FLOW CYTOMETERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 187
TABLE 162 EUROPE: FLOW CYTOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 187
TABLE 163 ASIA PACIFIC: FLOW CYTOMETERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 187
TABLE 164 LATIN AMERICA: FLOW CYTOMETERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 188
TABLE 165 MIDDLE EAST: FLOW CYTOMETERS MARKET, BY REGION,
2022–2029 (USD MILLION) 188
TABLE 166 GCC COUNTRIES: FLOW CYTOMETERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 188
TABLE 167 ELECTROPHORESIS EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION) 189
TABLE 168 NORTH AMERICA: ELECTROPHORESIS EQUIPMENT MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 189
TABLE 169 EUROPE: ELECTROPHORESIS EQUIPMENT MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 190
TABLE 170 ASIA PACIFIC: ELECTROPHORESIS EQUIPMENT MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 190
TABLE 171 LATIN AMERICA: ELECTROPHORESIS EQUIPMENT MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 191
TABLE 172 MIDDLE EAST: ELECTROPHORESIS EQUIPMENT MARKET, BY REGION,
2022–2029 (USD MILLION) 191
TABLE 173 GCC COUNTRIES: ELECTROPHORESIS EQUIPMENT MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 191
TABLE 174 FILTRATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 192
TABLE 175 NORTH AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 193
TABLE 176 EUROPE: FILTRATION SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 193
TABLE 177 ASIA PACIFIC: FILTRATION SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 193
TABLE 178 LATIN AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 194
TABLE 179 MIDDLE EAST: FILTRATION SYSTEMS MARKET, BY REGION,
2022–2029 (USD MILLION) 194
TABLE 180 GCC COUNTRIES: FILTRATION SYSTEMS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 194
TABLE 181 MIXERS & SHAKERS MARKET, BY REGION, 2022–2029 (USD MILLION) 195
TABLE 182 NORTH AMERICA: MIXERS & SHAKERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 195
TABLE 183 EUROPE: MIXERS & SHAKERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 196
TABLE 184 ASIA PACIFIC: MIXERS & SHAKERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 196
TABLE 185 LATIN AMERICA: MIXERS & SHAKERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 196
TABLE 186 MIDDLE EAST: MIXERS & SHAKERS MARKET, BY REGION,
2022–2029 (USD MILLION) 197
TABLE 187 GCC COUNTRIES: MIXERS & SHAKERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 197
TABLE 188 INCUBATORS MARKET, BY REGION, 2022–2029 (USD MILLION) 198
TABLE 189 NORTH AMERICA: INCUBATORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 198
TABLE 190 EUROPE: INCUBATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 198
TABLE 191 ASIA PACIFIC: INCUBATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 199
TABLE 192 LATIN AMERICA: INCUBATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 199
TABLE 193 MIDDLE EAST: INCUBATORS MARKET, BY REGION, 2022–2029 (USD MILLION) 199
TABLE 194 GCC COUNTRIES: INCUBATORS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 200
TABLE 195 OTHER BIOCONJUGATION INSTRUMENTS MARKET, BY REGION,
2022–2029 (USD MILLION) 200
TABLE 196 NORTH AMERICA: OTHER BIOCONJUGATION INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 201
TABLE 197 EUROPE: OTHER BIOCONJUGATION INSTRUMENTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 201
TABLE 198 ASIA PACIFIC: OTHER BIOCONJUGATION INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 201
TABLE 199 LATIN AMERICA: OTHER BIOCONJUGATION INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 202
TABLE 200 MIDDLE EAST: OTHER BIOCONJUGATION INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 202
TABLE 201 GCC COUNTRIES: OTHER BIOCONJUGATION INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 202
TABLE 202 BIOCONJUGATION PRODUCTS MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 204
TABLE 203 BIOCONJUGATION PRODUCTS MARKET FOR CHEMICAL CONJUGATION, BY REGION, 2022–2029 (USD MILLION) 205
TABLE 204 NORTH AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR CHEMICAL CONJUGATION, BY COUNTRY, 2022–2029 (USD MILLION) 205
TABLE 205 EUROPE: BIOCONJUGATION PRODUCTS MARKET FOR CHEMICAL CONJUGATION,
BY COUNTRY, 2022–2029 (USD MILLION) 206
TABLE 206 ASIA PACIFIC: BIOCONJUGATION PRODUCTS MARKET FOR CHEMICAL CONJUGATION, BY COUNTRY, 2022–2029 (USD MILLION) 206
TABLE 207 LATIN AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR CHEMICAL CONJUGATION, BY COUNTRY, 2022–2029 (USD MILLION) 207
TABLE 208 MIDDLE EAST: BIOCONJUGATION PRODUCTS MARKET FOR CHEMICAL CONJUGATION, BY REGION, 2022–2029 (USD MILLION) 207
TABLE 209 GCC COUNTRIES: BIOCONJUGATION PRODUCTS MARKET FOR CHEMICAL CONJUGATION, BY COUNTRY, 2022–2029 (USD MILLION) 207
TABLE 210 APPLICATION OF COPPER-CATALYZED AZIDE-ALKYNE CYCLOADDITION REACTION IN SYNTHESIS OF ANTIBODY-DRUG CONJUGATES 208
TABLE 211 BIOCONJUGATION PRODUCTS MARKET FOR CLICK CHEMISTRY, BY REGION,
2022–2029 (USD MILLION) 209
TABLE 212 NORTH AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR CLICK CHEMISTRY, BY COUNTRY, 2022–2029 (USD MILLION) 209
TABLE 213 EUROPE: BIOCONJUGATION PRODUCTS MARKET FOR CLICK CHEMISTRY,
BY COUNTRY, 2022–2029 (USD MILLION) 209
TABLE 214 ASIA PACIFIC: BIOCONJUGATION PRODUCTS MARKET FOR CLICK CHEMISTRY,
BY COUNTRY, 2022–2029 (USD MILLION) 210
TABLE 215 LATIN AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR CLICK CHEMISTRY,
BY COUNTRY, 2022–2029 (USD MILLION) 210
TABLE 216 MIDDLE EAST: BIOCONJUGATION PRODUCTS MARKET FOR CLICK CHEMISTRY,
BY REGION, 2022–2029 (USD MILLION) 210
TABLE 217 GCC COUNTRIES: BIOCONJUGATION PRODUCTS MARKET FOR CLICK CHEMISTRY, BY COUNTRY, 2022–2029 (USD MILLION) 211
TABLE 218 BIOCONJUGATION PRODUCTS MARKET FOR ENZYME-MEDIATED CONJUGATION,
BY REGION, 2022–2029 (USD MILLION) 212
TABLE 219 NORTH AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR ENZYME-MEDIATED CONJUGATION, BY COUNTRY, 2022–2029 (USD MILLION) 212
TABLE 220 EUROPE: BIOCONJUGATION PRODUCTS MARKET FOR ENZYME-MEDIATED CONJUGATION, BY COUNTRY, 2022–2029 (USD MILLION) 212
TABLE 221 ASIA PACIFIC: BIOCONJUGATION PRODUCTS MARKET FOR ENZYME-MEDIATED CONJUGATION, BY COUNTRY, 2022–2029 (USD MILLION) 213
TABLE 222 LATIN AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR ENZYME-MEDIATED CONJUGATION, BY COUNTRY, 2022–2029 (USD MILLION) 213
TABLE 223 MIDDLE EAST: BIOCONJUGATION PRODUCTS MARKET FOR ENZYME-MEDIATED CONJUGATION, BY REGION, 2022–2029 (USD MILLION) 213
TABLE 224 GCC COUNTRIES: BIOCONJUGATION PRODUCTS MARKET FOR ENZYME-MEDIATED CONJUGATION, BY COUNTRY, 2022–2029 (USD MILLION) 214
TABLE 225 BIOCONJUGATION PRODUCTS MARKET FOR PHOTOREACTIVE CROSSLINKING,
BY REGION, 2022–2029 (USD MILLION) 215
TABLE 226 NORTH AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR PHOTOREACTIVE CROSSLINKING, BY COUNTRY, 2022–2029 (USD MILLION) 215
TABLE 227 EUROPE: BIOCONJUGATION PRODUCTS MARKET FOR PHOTOREACTIVE CROSSLINKING, BY COUNTRY, 2022–2029 (USD MILLION) 215
TABLE 228 ASIA PACIFIC: BIOCONJUGATION PRODUCTS MARKET FOR PHOTOREACTIVE CROSSLINKING, BY COUNTRY, 2022–2029 (USD MILLION) 216
TABLE 229 LATIN AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR PHOTOREACTIVE CROSSLINKING, BY COUNTRY, 2022–2029 (USD MILLION) 216
TABLE 230 MIDDLE EAST: BIOCONJUGATION PRODUCTS MARKET FOR PHOTOREACTIVE CROSSLINKING, BY REGION, 2022–2029 (USD MILLION) 216
TABLE 231 GCC COUNTRIES: BIOCONJUGATION PRODUCTS MARKET FOR PHOTOREACTIVE CROSSLINKING, BY COUNTRY, 2022–2029 (USD MILLION) 217
TABLE 232 BIOCONJUGATION PRODUCTS MARKET FOR OTHER TECHNIQUES, BY REGION, 2022–2029 (USD MILLION) 218
TABLE 233 NORTH AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION) 218
TABLE 234 EUROPE: BIOCONJUGATION PRODUCTS MARKET FOR OTHER TECHNIQUES,
BY COUNTRY, 2022–2029 (USD MILLION) 218
TABLE 235 ASIA PACIFIC: BIOCONJUGATION PRODUCTS MARKET FOR OTHER TECHNIQUES,
BY COUNTRY, 2022–2029 (USD MILLION) 219
TABLE 236 LATIN AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION) 219
TABLE 237 MIDDLE EAST: BIOCONJUGATION PRODUCTS MARKET FOR OTHER TECHNIQUES, BY REGION, 2022–2029 (USD MILLION) 219
TABLE 238 GCC COUNTRIES: BIOCONJUGATION PRODUCTS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION) 220
TABLE 239 BIOCONJUGATION PRODUCTS MARKET, BY BIOMOLECULE TYPE,
2022–2029 (USD MILLION) 222
TABLE 240 BIOCONJUGATION PRODUCTS MARKET FOR ANTIBODIES, BY REGION,
2022–2029 (USD MILLION) 223
TABLE 241 NORTH AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR ANTIBODIES,
BY COUNTRY, 2022–2029 (USD MILLION) 223
TABLE 242 EUROPE: BIOCONJUGATION PRODUCTS MARKET FOR ANTIBODIES, BY COUNTRY, 2022–2029 (USD MILLION) 223
TABLE 243 ASIA PACIFIC: BIOCONJUGATION PRODUCTS MARKET FOR ANTIBODIES,
BY COUNTRY, 2022–2029 (USD MILLION) 224
TABLE 244 LATIN AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR ANTIBODIES,
BY COUNTRY, 2022–2029 (USD MILLION) 224
TABLE 245 MIDDLE EAST: BIOCONJUGATION PRODUCTS MARKET FOR ANTIBODIES,
BY REGION, 2022–2029 (USD MILLION) 224
TABLE 246 GCC COUNTRIES: BIOCONJUGATION PRODUCTS MARKET FOR ANTIBODIES,
BY COUNTRY, 2022–2029 (USD MILLION) 225
TABLE 247 BIOCONJUGATION PRODUCTS MARKET FOR PEPTIDES, BY REGION,
2022–2029 (USD MILLION) 226
TABLE 248 NORTH AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR PEPTIDES,
BY COUNTRY, 2022–2029 (USD MILLION) 226
TABLE 249 EUROPE: BIOCONJUGATION PRODUCTS MARKET FOR PEPTIDES, BY COUNTRY, 2022–2029 (USD MILLION) 226
TABLE 250 ASIA PACIFIC: BIOCONJUGATION PRODUCTS MARKET FOR PEPTIDES, BY COUNTRY, 2022–2029 (USD MILLION) 227
TABLE 251 LATIN AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR PEPTIDES,
BY COUNTRY, 2022–2029 (USD MILLION) 227
TABLE 252 MIDDLE EAST: BIOCONJUGATION PRODUCTS MARKET FOR PEPTIDES, BY REGION, 2022–2029 (USD MILLION) 227
TABLE 253 GCC COUNTRIES: BIOCONJUGATION PRODUCTS MARKET FOR PEPTIDES,
BY COUNTRY, 2022–2029 (USD MILLION) 228
TABLE 254 BIOCONJUGATION PRODUCTS MARKET FOR PROTEINS, BY REGION,
2022–2029 (USD MILLION) 229
TABLE 255 NORTH AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR PROTEINS,
BY COUNTRY, 2022–2029 (USD MILLION) 229
TABLE 256 EUROPE: BIOCONJUGATION PRODUCTS MARKET FOR PROTEINS, BY COUNTRY, 2022–2029 (USD MILLION) 229
TABLE 257 ASIA PACIFIC: BIOCONJUGATION PRODUCTS MARKET FOR PROTEINS, BY COUNTRY, 2022–2029 (USD MILLION) 230
TABLE 258 LATIN AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR PROTEINS,
BY COUNTRY, 2022–2029 (USD MILLION) 230
TABLE 259 MIDDLE EAST: BIOCONJUGATION PRODUCTS MARKET FOR PROTEINS, BY REGION, 2022–2029 (USD MILLION) 230
TABLE 260 GCC COUNTRIES: BIOCONJUGATION PRODUCTS MARKET FOR PROTEINS,
BY COUNTRY, 2022–2029 (USD MILLION) 231
TABLE 261 BIOCONJUGATION PRODUCTS MARKET FOR OLIGONUCLEOTIDES, BY REGION, 2022–2029 (USD MILLION) 231
TABLE 262 NORTH AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR OLIGONUCLEOTIDES, BY COUNTRY, 2022–2029 (USD MILLION) 232
TABLE 263 EUROPE: BIOCONJUGATION PRODUCTS MARKET FOR OLIGONUCLEOTIDES,
BY COUNTRY, 2022–2029 (USD MILLION) 232
TABLE 264 ASIA PACIFIC: BIOCONJUGATION PRODUCTS MARKET FOR OLIGONUCLEOTIDES,
BY COUNTRY, 2022–2029 (USD MILLION) 232
TABLE 265 LATIN AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR OLIGONUCLEOTIDES, BY COUNTRY, 2022–2029 (USD MILLION) 233
TABLE 266 MIDDLE EAST: BIOCONJUGATION PRODUCTS MARKET FOR OLIGONUCLEOTIDES, BY REGION, 2022–2029 (USD MILLION) 233
TABLE 267 GCC COUNTRIES: BIOCONJUGATION PRODUCTS MARKET FOR OLIGONUCLEOTIDES, BY COUNTRY, 2022–2029 (USD MILLION) 233
TABLE 268 BIOCONJUGATION PRODUCTS MARKET FOR OTHER BIOMOLECULES, BY REGION, 2022–2029 (USD MILLION) 234
TABLE 269 NORTH AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR OTHER BIOMOLECULES, BY COUNTRY, 2022–2029 (USD MILLION) 234
TABLE 270 EUROPE: BIOCONJUGATION PRODUCTS MARKET FOR OTHER BIOMOLECULES,
BY COUNTRY, 2022–2029 (USD MILLION) 235
TABLE 271 ASIA PACIFIC: BIOCONJUGATION PRODUCTS MARKET FOR OTHER BIOMOLECULES, BY COUNTRY, 2022–2029 (USD MILLION) 235
TABLE 272 LATIN AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR OTHER BIOMOLECULES, BY COUNTRY, 2022–2029 (USD MILLION) 236
TABLE 273 MIDDLE EAST: BIOCONJUGATION PRODUCTS MARKET FOR OTHER BIOMOLECULES, BY REGION, 2022–2029 (USD MILLION) 236
TABLE 274 GCC COUNTRIES: BIOCONJUGATION PRODUCTS MARKET FOR OTHER BIOMOLECULES, BY COUNTRY, 2022–2029 (USD MILLION) 236
TABLE 275 BIOCONJUGATION PRODUCTS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 238
TABLE 276 FDA-APPROVED ADC DRUGS 238
TABLE 277 BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS,
BY TYPE, 2022–2029 (USD MILLION) 240
TABLE 278 BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS,
BY REGION, 2022–2029 (USD MILLION) 240
TABLE 279 NORTH AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 240
TABLE 280 EUROPE: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 241
TABLE 281 ASIA PACIFIC: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 241
TABLE 282 LATIN AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 242
TABLE 283 MIDDLE EAST: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 242
TABLE 284 GCC COUNTRIES: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 242
TABLE 285 THERAPEUTIC APPLICATIONS MARKET FOR ANTIBODY-DRUG CONJUGATES,
BY REGION, 2022–2029 (USD MILLION) 244
TABLE 286 NORTH AMERICA: THERAPEUTICS APPLICATIONS MARKET FOR ANTIBODY-DRUG CONJUGATES, BY COUNTRY, 2022–2029 (USD MILLION) 244
TABLE 287 EUROPE: THERAPEUTICS APPLICATIONS MARKET FOR ANTIBODY-DRUG CONJUGATES, BY COUNTRY, 2022–2029 (USD MILLION) 244
TABLE 288 ASIA PACIFIC: THERAPEUTIC APPLICATIONS MARKET FOR ANTIBODY-DRUG CONJUGATES, BY COUNTRY, 2022–2029 (USD MILLION) 245
TABLE 289 LATIN AMERICA: THERAPEUTIC APPLICATIONS MARKET FOR ANTIBODY-DRUG CONJUGATES, BY COUNTRY, 2022–2029 (USD MILLION) 245
TABLE 290 MIDDLE EAST: THERAPEUTIC APPLICATIONS MARKET FOR ANTIBODY-DRUG CONJUGATES, BY COUNTRY, 2022–2029 (USD MILLION) 245
TABLE 291 GCC COUNTRIES: THERAPEUTIC APPLICATIONS MARKET FOR ANTIBODY-DRUG CONJUGATES, BY COUNTRY, 2022–2029 (USD MILLION) 246
TABLE 292 COMPARISON OF PDC AND ADC 247
TABLE 293 THERAPEUTIC APPLICATIONS MARKET FOR PEPTIDE-DRUG CONJUGATES,
BY REGION, 2022–2029 (USD MILLION) 247
TABLE 294 NORTH AMERICA: THERAPEUTIC APPLICATIONS MARKET FOR PEPTIDE-DRUG CONJUGATES, BY COUNTRY, 2022–2029 (USD MILLION) 248
TABLE 295 EUROPE: THERAPEUTIC APPLICATIONS MARKET FOR PEPTIDE-DRUG CONJUGATES, BY COUNTRY, 2022–2029 (USD MILLION) 248
TABLE 296 ASIA PACIFIC: THERAPEUTIC APPLICATIONS MARKET FOR PEPTIDE-DRUG CONJUGATES, BY COUNTRY, 2022–2029 (USD MILLION) 248
TABLE 297 LATIN AMERICA: THERAPEUTIC APPLICATIONS MARKET FOR PEPTIDE-DRUG CONJUGATES, BY COUNTRY, 2022–2029 (USD MILLION) 249
TABLE 298 MIDDLE EAST: THERAPEUTIC APPLICATIONS MARKET FOR PEPTIDE-DRUG CONJUGATES, BY REGION, 2022–2029 (USD MILLION) 249
TABLE 299 GCC COUNTRIES: THERAPEUTIC APPLICATIONS MARKET FOR PEPTIDE-DRUG CONJUGATES, BY COUNTRY, 2022–2029 (USD MILLION) 249
TABLE 300 THERAPEUTIC APPLICATIONS MARKET FOR PROTEIN-DRUG CONJUGATES,
BY REGION, 2022–2029 (USD MILLION) 250
TABLE 301 NORTH AMERICA: THERAPEUTIC APPLICATIONS MARKET FOR PROTEIN-DRUG CONJUGATES, BY COUNTRY, 2022–2029 (USD MILLION) 251
TABLE 302 EUROPE: THERAPEUTIC APPLICATIONS MARKET FOR PROTEIN-DRUG CONJUGATES, BY COUNTRY, 2022–2029 (USD MILLION) 251
TABLE 303 ASIA PACIFIC: THERAPEUTIC APPLICATIONS MARKET FOR PROTEIN-DRUG CONJUGATES, BY COUNTRY, 2022–2029 (USD MILLION) 251
TABLE 304 LATIN AMERICA: THERAPEUTIC APPLICATIONS MARKET FOR PROTEIN-DRUG CONJUGATES, BY COUNTRY, 2022–2029 (USD MILLION) 252
TABLE 305 MIDDLE EAST: THERAPEUTIC APPLICATIONS MARKET FOR PROTEIN-DRUG CONJUGATES, BY REGION, 2022–2029 (USD MILLION) 252
TABLE 306 GCC COUNTRIES: THERAPEUTIC APPLICATIONS MARKET FOR PROTEIN-DRUG CONJUGATES, BY COUNTRY, 2022–2029 (USD MILLION) 252
TABLE 307 OTHER THERAPEUTIC APPLICATIONS MARKET, BY REGION,
2022–2029 (USD MILLION) 253
TABLE 308 NORTH AMERICA: OTHER THERAPEUTIC APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 253
TABLE 309 EUROPE: OTHER THERAPEUTIC APPLICATIONS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 254
TABLE 310 ASIA PACIFIC: OTHER THERAPEUTIC APPLICATIONS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 254
TABLE 311 LATIN AMERICA: OTHER THERAPEUTIC APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 255
TABLE 312 MIDDLE EAST: OTHER THERAPEUTIC APPLICATIONS MARKET, BY REGION,
2022–2029 (USD MILLION) 255
TABLE 313 GCC COUNTRIES: OTHER THERAPEUTIC APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 255
TABLE 314 BIOCONJUGATION PRODUCTS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 257
TABLE 315 NORTH AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 257
TABLE 316 EUROPE: BIOCONJUGATION PRODUCTS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 257
TABLE 317 ASIA PACIFIC: BIOCONJUGATION PRODUCTS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 258
TABLE 318 LATIN AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 258
TABLE 319 MIDDLE EAST: BIOCONJUGATION PRODUCTS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 258
TABLE 320 GCC COUNTRIES: BIOCONJUGATION PRODUCTS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 259
TABLE 321 BIOCONJUGATION PRODUCTS MARKET FOR DIAGNOSTIC APPLICATIONS,
BY REGION, 2022–2029 (USD MILLION) 260
TABLE 322 NORTH AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 260
TABLE 323 EUROPE: BIOCONJUGATION PRODUCTS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 260
TABLE 324 ASIA PACIFIC: BIOCONJUGATION PRODUCTS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 261
TABLE 325 LATIN AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 261
TABLE 326 MIDDLE EAST: BIOCONJUGATION PRODUCTS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 261
TABLE 327 GCC COUNTRIES: BIOCONJUGATION PRODUCTS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 262
TABLE 328 BIOCONJUGATION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 264
TABLE 329 BIOCONJUGATION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 265
TABLE 330 NORTH AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 265
TABLE 331 EUROPE: BIOCONJUGATION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 266
TABLE 332 ASIA PACIFIC: BIOCONJUGATION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 266
TABLE 333 LATIN AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 267
TABLE 334 MIDDLE EAST: BIOCONJUGATION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 267
TABLE 335 GCC COUNTRIES: BIOCONJUGATION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 267
TABLE 336 BIOCONJUGATION PRODUCTS MARKET FOR CROS & CMOS, BY REGION,
2022–2029 (USD MILLION) 269
TABLE 337 NORTH AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR CROS & CMOS,
BY COUNTRY, 2022–2029 (USD MILLION) 269
TABLE 338 EUROPE: BIOCONJUGATION PRODUCTS MARKET FOR CROS & CMOS, BY COUNTRY, 2022–2029 (USD MILLION) 269
TABLE 339 ASIA PACIFIC: BIOCONJUGATION PRODUCTS MARKET FOR CROS & CMOS,
BY COUNTRY, 2022–2029 (USD MILLION) 270
TABLE 340 LATIN AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR CROS & CMOS,
BY COUNTRY, 2022–2029 (USD MILLION) 270
TABLE 341 MIDDLE EAST: BIOCONJUGATION PRODUCTS MARKET FOR CROS & CMOS,
BY REGION, 2022–2029 (USD MILLION) 270
TABLE 342 GCC COUNTRIES: BIOCONJUGATION PRODUCTS MARKET FOR CROS & CMOS,
BY COUNTRY, 2022–2029 (USD MILLION) 271
TABLE 343 BIOCONJUGATION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION) 272
TABLE 344 NORTH AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 272
TABLE 345 EUROPE: BIOCONJUGATION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 272
TABLE 346 ASIA PACIFIC: BIOCONJUGATION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 273
TABLE 347 LATIN AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 273
TABLE 348 MIDDLE EAST: BIOCONJUGATION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION) 273
TABLE 349 GCC COUNTRIES: BIOCONJUGATION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 274
TABLE 350 BIOCONJUGATION PRODUCTS MARKET FOR HOSPITALS AND CLINICAL/DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION) 275
TABLE 351 NORTH AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR HOSPITALS AND CLINICAL/DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION) 275
TABLE 352 EUROPE: BIOCONJUGATION PRODUCTS MARKET FOR HOSPITALS AND CLINICAL/DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION) 275
TABLE 353 ASIA PACIFIC: BIOCONJUGATION PRODUCTS MARKET FOR HOSPITALS AND CLINICAL/DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION) 276
TABLE 354 LATIN AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR HOSPITALS AND CLINICAL/DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION) 276
TABLE 355 MIDDLE EAST: BIOCONJUGATION PRODUCTS MARKET FOR HOSPITALS AND CLINICAL/DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION) 276
TABLE 356 GCC COUNTRIES: BIOCONJUGATION PRODUCTS MARKET FOR HOSPITALS AND CLINICAL/DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION) 277
TABLE 357 BIOCONJUGATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 279
TABLE 358 BIOCONJUGATION CUSTOM SYNTHESIS & CONJUGATION SERVICES MARKET,
BY REGION, 2022–2029 (USD MILLION) 280
TABLE 359 NORTH AMERICA: BIOCONJUGATION CUSTOM SYNTHESIS & CONJUGATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 280
TABLE 360 EUROPE: BIOCONJUGATION CUSTOM SYNTHESIS & CONJUGATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 281
TABLE 361 ASIA PACIFIC: BIOCONJUGATION CUSTOM SYNTHESIS & CONJUGATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 281
TABLE 362 LATIN AMERICA: BIOCONJUGATION CUSTOM SYNTHESIS & CONJUGATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 282
TABLE 363 MIDDLE EAST: BIOCONJUGATION CUSTOM SYNTHESIS & CONJUGATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 282
TABLE 364 GCC COUNTRIES: BIOCONJUGATION CUSTOM SYNTHESIS & CONJUGATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 282
TABLE 365 KEY BIOCONJUGATION CHARACTERIZATION TECHNIQUES 283
TABLE 366 BIOCONJUGATION ANALYTICAL & CHARACTERIZATION SERVICES MARKET,
BY REGION, 2022–2029 (USD MILLION) 284
TABLE 367 NORTH AMERICA: BIOCONJUGATION ANALYTICAL & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 284
TABLE 368 EUROPE: BIOCONJUGATION ANALYTICAL & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 284
TABLE 369 ASIA PACIFIC: BIOCONJUGATION ANALYTICAL & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 285
TABLE 370 LATIN AMERICA: BIOCONJUGATION ANALYTICAL & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 285
TABLE 371 MIDDLE EAST: BIOCONJUGATION ANALYTICAL & CHARACTERIZATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 285
TABLE 372 GCC COUNTRIES: BIOCONJUGATION ANALYTICAL & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 286
TABLE 373 BIOCONJUGATION SCALE-UP & MANUFACTURING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 287
TABLE 374 NORTH AMERICA: BIOCONJUGATION SCALE-UP & MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 287
TABLE 375 EUROPE: BIOCONJUGATION SCALE-UP & MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 287
TABLE 376 ASIA PACIFIC: BIOCONJUGATION SCALE-UP & MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 288
TABLE 377 LATIN AMERICA: BIOCONJUGATION SCALE-UP & MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 288
TABLE 378 MIDDLE EAST: BIOCONJUGATION SCALE-UP & MANUFACTURING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 288
TABLE 379 GCC COUNTRIES: BIOCONJUGATION SCALE-UP & MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 289
TABLE 380 OTHER BIOCONJUGATION SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION) 289
TABLE 381 NORTH AMERICA: OTHER BIOCONJUGATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 290
TABLE 382 EUROPE: OTHER BIOCONJUGATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 290
TABLE 383 ASIA PACIFIC: OTHER BIOCONJUGATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 290
TABLE 384 LATIN AMERICA: OTHER BIOCONJUGATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 291
TABLE 385 MIDDLE EAST: OTHER BIOCONJUGATION SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION) 291
TABLE 386 GCC COUNTRIES: OTHER BIOCONJUGATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 291
TABLE 387 BIOCONJUGATION SERVICES MARKET, BY CONJUGATION TYPE,
2022–2029 (USD MILLION) 293
TABLE 388 ANTIBODY CONJUGATION SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION) 294
TABLE 389 NORTH AMERICA: ANTIBODY CONJUGATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 295
TABLE 390 EUROPE: ANTIBODY CONJUGATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 295
TABLE 391 ASIA PACIFIC: ANTIBODY CONJUGATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 295
TABLE 392 LATIN AMERICA: ANTIBODY CONJUGATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 296
TABLE 393 MIDDLE EAST: ANTIBODY CONJUGATION SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION) 296
TABLE 394 GCC COUNTRIES: ANTIBODY CONJUGATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 296
TABLE 395 PEPTIDE CONJUGATION SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION) 298
TABLE 396 NORTH AMERICA: PEPTIDE CONJUGATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 298
TABLE 397 EUROPE: PEPTIDE CONJUGATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 298
TABLE 398 ASIA PACIFIC: PEPTIDE CONJUGATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 299
TABLE 399 LATIN AMERICA: PEPTIDE CONJUGATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 299
TABLE 400 MIDDLE EAST: PEPTIDE CONJUGATION SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION) 299
TABLE 401 GCC COUNTRIES: PEPTIDE CONJUGATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 300
TABLE 402 PROTEIN CONJUGATION SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION) 301
TABLE 403 NORTH AMERICA: PROTEIN CONJUGATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 302
TABLE 404 EUROPE: PROTEIN CONJUGATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 302
TABLE 405 ASIA PACIFIC: PROTEIN CONJUGATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 302
TABLE 406 LATIN AMERICA: PROTEIN CONJUGATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 303
TABLE 407 MIDDLE EAST: PROTEIN CONJUGATION SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION) 303
TABLE 408 GCC COUNTRIES: PROTEIN CONJUGATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 303
TABLE 409 OLIGONUCLEOTIDE CONJUGATION SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION) 305
TABLE 410 NORTH AMERICA: OLIGONUCLEOTIDE CONJUGATION SERVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 305
TABLE 411 EUROPE: OLIGONUCLEOTIDE CONJUGATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 305
TABLE 412 ASIA PACIFIC: OLIGONUCLEOTIDE CONJUGATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 306
TABLE 413 LATIN AMERICA: OLIGONUCLEOTIDE CONJUGATION SERVICES MARKET,
BY REGION, 2022–2029 (USD MILLION) 306
TABLE 414 MIDDLE EAST: OLIGONUCLEOTIDE CONJUGATION SERVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 306
TABLE 415 GCC COUNTRIES: OLIGONUCLEOTIDE CONJUGATION SERVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 307
TABLE 416 OTHER CONJUGATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 308
TABLE 417 NORTH AMERICA: OTHER CONJUGATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 309
TABLE 418 EUROPE: OTHER CONJUGATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 309
TABLE 419 ASIA PACIFIC: OTHER CONJUGATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 309
TABLE 420 LATIN AMERICA: OTHER CONJUGATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 310
TABLE 421 MIDDLE EAST: OTHER CONJUGATION SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION) 310
TABLE 422 GCC COUNTRIES: OTHER CONJUGATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 310
TABLE 423 BIOCONJUGATION SERVICES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 312
TABLE 424 BIOCONJUGATION SERVICES MARKET FOR CHEMICAL CONJUGATION, BY REGION, 2022–2029 (USD MILLION) 313
TABLE 425 NORTH AMERICA: BIOCONJUGATION SERVICES MARKET FOR CHEMICAL CONJUGATION, BY COUNTRY, 2022–2029 (USD MILLION) 313
TABLE 426 EUROPE: BIOCONJUGATION SERVICES MARKET FOR CHEMICAL CONJUGATION,
BY COUNTRY, 2022–2029 (USD MILLION) 314
TABLE 427 ASIA PACIFIC: BIOCONJUGATION SERVICES MARKET FOR CHEMICAL CONJUGATION, BY COUNTRY, 2022–2029 (USD MILLION) 314
TABLE 428 LATIN AMERICA: BIOCONJUGATION SERVICES MARKET FOR CHEMICAL CONJUGATION, BY COUNTRY, 2022–2029 (USD MILLION) 315
TABLE 429 MIDDLE EAST: BIOCONJUGATION SERVICES MARKET FOR CHEMICAL CONJUGATION, BY REGION, 2022–2029 (USD MILLION) 315
TABLE 430 GCC COUNTRIES: BIOCONJUGATION SERVICES MARKET FOR CHEMICAL CONJUGATION, BY COUNTRY, 2022–2029 (USD MILLION) 315
TABLE 431 BIOCONJUGATION SERVICES MARKET FOR CLICK CHEMISTRY, BY REGION,
2022–2029 (USD MILLION) 316
TABLE 432 NORTH AMERICA: BIOCONJUGATION SERVICES MARKET FOR CLICK CHEMISTRY, BY COUNTRY, 2022–2029 (USD MILLION) 317
TABLE 433 EUROPE: BIOCONJUGATION SERVICES MARKET FOR CLICK CHEMISTRY,
BY COUNTRY, 2022–2029 (USD MILLION) 317
TABLE 434 ASIA PACIFIC: BIOCONJUGATION SERVICES MARKET FOR CLICK CHEMISTRY,
BY COUNTRY, 2022–2029 (USD MILLION) 317
TABLE 435 LATIN AMERICA: BIOCONJUGATION SERVICES MARKET FOR CLICK CHEMISTRY,
BY COUNTRY, 2022–2029 (USD MILLION) 318
TABLE 436 MIDDLE EAST: BIOCONJUGATION SERVICES MARKET FOR CLICK CHEMISTRY,
BY REGION, 2022–2029 (USD MILLION) 318
TABLE 437 GCC COUNTRIES: BIOCONJUGATION SERVICES MARKET FOR CLICK CHEMISTRY,
BY COUNTRY, 2022–2029 (USD MILLION) 318
TABLE 438 BIOCONJUGATION SERVICES MARKET FOR ENZYME-MEDIATED CONJUGATION,
BY REGION, 2022–2029 (USD MILLION) 319
TABLE 439 NORTH AMERICA: BIOCONJUGATION SERVICES MARKET FOR ENZYME-MEDIATED CONJUGATION, BY COUNTRY, 2022–2029 (USD MILLION) 320
TABLE 440 EUROPE: BIOCONJUGATION SERVICES MARKET FOR ENZYME-MEDIATED CONJUGATION, BY COUNTRY, 2022–2029 (USD MILLION) 320
TABLE 441 ASIA PACIFIC: BIOCONJUGATION SERVICES MARKET FOR ENZYME-MEDIATED CONJUGATION, BY COUNTRY, 2022–2029 (USD MILLION) 320
TABLE 442 LATIN AMERICA: BIOCONJUGATION SERVICES MARKET FOR ENZYME-MEDIATED CONJUGATION, BY COUNTRY, 2022–2029 (USD MILLION) 321
TABLE 443 MIDDLE EAST: BIOCONJUGATION SERVICES MARKET FOR ENZYME-MEDIATED CONJUGATION, BY REGION, 2022–2029 (USD MILLION) 321
TABLE 444 GCC COUNTRIES: BIOCONJUGATION SERVICES MARKET FOR ENZYME-MEDIATED CONJUGATION, BY COUNTRY, 2022–2029 (USD MILLION) 321
TABLE 445 BIOCONJUGATION SERVICES MARKET FOR PHOTOREACTIVE CROSSLINKING,
BY REGION, 2022–2029 (USD MILLION) 322
TABLE 446 NORTH AMERICA: BIOCONJUGATION SERVICES MARKET FOR PHOTOREACTIVE CROSSLINKING, BY COUNTRY, 2022–2029 (USD MILLION) 323
TABLE 447 EUROPE: BIOCONJUGATION SERVICES MARKET FOR PHOTOREACTIVE CROSSLINKING, BY COUNTRY, 2022–2029 (USD MILLION) 323
TABLE 448 ASIA PACIFIC: BIOCONJUGATION SERVICES MARKET FOR PHOTOREACTIVE CROSSLINKING, BY COUNTRY, 2022–2029 (USD MILLION) 323
TABLE 449 LATIN AMERICA: BIOCONJUGATION SERVICES MARKET FOR PHOTOREACTIVE CROSSLINKING, BY COUNTRY, 2022–2029 (USD MILLION) 324
TABLE 450 MIDDLE EAST: BIOCONJUGATION SERVICES MARKET FOR PHOTOREACTIVE CROSSLINKING, BY REGION, 2022–2029 (USD MILLION) 324
TABLE 451 GCC COUNTRIES: BIOCONJUGATION SERVICES MARKET FOR PHOTOREACTIVE CROSSLINKING, BY COUNTRY, 2022–2029 (USD MILLION) 324
TABLE 452 BIOCONJUGATION SERVICES MARKET FOR OTHER TECHNIQUES, BY REGION, 2022–2029 (USD MILLION) 325
TABLE 453 NORTH AMERICA: BIOCONJUGATION SERVICES MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION) 326
TABLE 454 EUROPE: BIOCONJUGATION SERVICES MARKET FOR OTHER TECHNIQUES,
BY COUNTRY, 2022–2029 (USD MILLION) 326
TABLE 455 ASIA PACIFIC: BIOCONJUGATION SERVICES MARKET FOR OTHER TECHNIQUES,
BY COUNTRY, 2022–2029 (USD MILLION) 326
TABLE 456 LATIN AMERICA: BIOCONJUGATION SERVICES MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION) 327
TABLE 457 MIDDLE EAST: BIOCONJUGATION SERVICES MARKET FOR OTHER TECHNIQUES,
BY COUNTRY, 2022–2029 (USD MILLION) 327
TABLE 458 GCC COUNTRIES: BIOCONJUGATION SERVICES MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION) 327
TABLE 459 BIOCONJUGATION SERVICES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 329
TABLE 460 BIOCONJUGATION SERVICES MARKET FOR THERAPEUTIC APPLICATIONS,
BY REGION, 2022–2029 (USD MILLION) 330
TABLE 461 NORTH AMERICA: BIOCONJUGATION SERVICES MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 330
TABLE 462 EUROPE: BIOCONJUGATION SERVICES MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 331
TABLE 463 ASIA PACIFIC: BIOCONJUGATION SERVICES MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 331
TABLE 464 LATIN AMERICA: BIOCONJUGATION SERVICES MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 332
TABLE 465 MIDDLE EAST: BIOCONJUGATION SERVICES MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 332
TABLE 466 GCC COUNTRIES: BIOCONJUGATION SERVICES MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 332
TABLE 467 BIOCONJUGATION SERVICES MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 334
TABLE 468 NORTH AMERICA: BIOCONJUGATION SERVICES MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 334
TABLE 469 EUROPE: BIOCONJUGATION SERVICES MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 334
TABLE 470 ASIA PACIFIC: BIOCONJUGATION SERVICES MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 335
TABLE 471 LATIN AMERICA: BIOCONJUGATION SERVICES MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 335
TABLE 472 MIDDLE EAST: BIOCONJUGATION SERVICES MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 335
TABLE 473 GCC COUNTRIES: BIOCONJUGATION SERVICES MARKET FOR RESEARCH & DEVELOPMENT APPLICATION, BY COUNTRY, 2022–2029 (USD MILLION) 336
TABLE 474 BIOCONJUGATION SERVICES MARKET FOR DIAGNOSTIC APPLICATIONS,
BY REGION, 2022–2029 (USD MILLION) 337
TABLE 475 NORTH AMERICA: BIOCONJUGATION SERVICES MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 337
TABLE 476 EUROPE: BIOCONJUGATION SERVICES MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 338
TABLE 477 ASIA PACIFIC: BIOCONJUGATION SERVICES MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 338
TABLE 478 LATIN AMERICA: BIOCONJUGATION SERVICES MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 339
TABLE 479 MIDDLE EAST: BIOCONJUGATION SERVICES MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 339
TABLE 480 GCC COUNTRIES: BIOCONJUGATION SERVICES MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 339
TABLE 481 BIOCONJUGATION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 341
TABLE 482 BIOCONJUGATION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 342
TABLE 483 NORTH AMERICA: BIOCONJUGATION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 342
TABLE 484 EUROPE: BIOCONJUGATION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 343
TABLE 485 ASIA PACIFIC: BIOCONJUGATION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 343
TABLE 486 LATIN AMERICA: BIOCONJUGATION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 344
TABLE 487 MIDDLE EAST: BIOCONJUGATION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 344
TABLE 488 GCC COUNTRIES: BIOCONJUGATION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 344
TABLE 489 BIOCONJUGATION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION) 345
TABLE 490 NORTH AMERICA: BIOCONJUGATION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 346
TABLE 491 EUROPE: BIOCONJUGATION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 346
TABLE 492 ASIA PACIFIC: BIOCONJUGATION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 346
TABLE 493 LATIN AMERICA: BIOCONJUGATION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 347
TABLE 494 MIDDLE EAST: BIOCONJUGATION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION) 347
TABLE 495 GCC COUNTRIES: BIOCONJUGATION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 347
TABLE 496 BIOCONJUGATION SERVICES MARKET FOR HOSPITALS AND CLINICAL/DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION) 348
TABLE 497 NORTH AMERICA: BIOCONJUGATION SERVICES MARKET FOR HOSPITALS AND CLINICAL/DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION) 349
TABLE 498 EUROPE: BIOCONJUGATION SERVICES MARKET FOR HOSPITALS AND CLINICAL/DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION) 349
TABLE 499 ASIA PACIFIC: BIOCONJUGATION SERVICES MARKET FOR HOSPITALS AND CLINICAL/DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION) 349
TABLE 500 LATIN AMERICA: BIOCONJUGATION SERVICES MARKET FOR HOSPITALS AND CLINICAL/DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION) 350
TABLE 501 MIDDLE EAST: BIOCONJUGATION SERVICES MARKET FOR HOSPITALS AND CLINICAL/DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION) 350
TABLE 502 GCC COUNTRIES: BIOCONJUGATION SERVICES MARKET FOR HOSPITALS AND CLINICAL/DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION) 350
TABLE 503 BIOCONJUGATION MARKET, BY REGION, 2022–2029 (USD MILLION) 352
TABLE 504 BIOCONJUGATION PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION) 352
TABLE 505 BIOCONJUGATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 353
TABLE 506 NORTH AMERICA: BIOCONJUGATION MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 354
TABLE 507 NORTH AMERICA: BIOCONJUGATION PRODUCTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 355
TABLE 508 NORTH AMERICA: BIOCONJUGATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 355
TABLE 509 NORTH AMERICA: BIOCONJUGATION PRODUCTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 355
TABLE 510 NORTH AMERICA: BIOCONJUGATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 356
TABLE 511 NORTH AMERICA: BIOCONJUGATION REAGENTS & KITS MARKET, BY TYPE,
2022–2029 (USD MILLION) 356
TABLE 512 NORTH AMERICA: BIOCONJUGATION LABELS MARKET, BY TYPE,
2022–2029 (USD MILLION) 357
TABLE 513 NORTH AMERICA: BIOCONJUGATION INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 357
TABLE 514 NORTH AMERICA: BIOCONJUGATION PRODUCTS MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 358
TABLE 515 NORTH AMERICA: BIOCONJUGATION PRODUCTS MARKET, BY BIOMOLECULE TYPE, 2022–2029 (USD MILLION) 358
TABLE 516 NORTH AMERICA: BIOCONJUGATION PRODUCTS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 358
TABLE 517 NORTH AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 359
TABLE 518 NORTH AMERICA: BIOCONJUGATION PRODUCTS MARKET, BY END USER,
2022–2029 (USD MILLION) 359
TABLE 519 NORTH AMERICA: BIOCONJUGATION SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 360
TABLE 520 NORTH AMERICA: BIOCONJUGATION SERVICES MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 360
TABLE 521 NORTH AMERICA: BIOCONJUGATION SERVICES MARKET, BY CONJUGATION TYPE, 2022–2029 (USD MILLION) 361
TABLE 522 NORTH AMERICA: BIOCONJUGATION SERVICES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 361
TABLE 523 NORTH AMERICA: BIOCONJUGATION SERVICES MARKET, BY END USER,
2022–2029 (USD MILLION) 361
TABLE 524 NORTH AMERICA: KEY MACROINDICATORS 362
TABLE 525 US: BIOCONJUGATION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 363
TABLE 526 US: BIOCONJUGATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 364
TABLE 527 US: BIOCONJUGATION REAGENTS & KITS MARKET, BY TYPE,
2022–2029 (USD MILLION) 364
TABLE 528 US: BIOCONJUGATION LABELS MARKET, BY TYPE, 2022–2029 (USD MILLION) 364
TABLE 529 US: BIOCONJUGATION INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 365
TABLE 530 US: BIOCONJUGATION PRODUCTS MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 365
TABLE 531 US: BIOCONJUGATION PRODUCTS MARKET, BY BIOMOLECULE TYPE,
2022–2029 (USD MILLION) 366
TABLE 532 US: BIOCONJUGATION PRODUCTS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 366
TABLE 533 US: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS,
BY TYPE, 2022–2029 (USD MILLION) 366
TABLE 534 US: BIOCONJUGATION PRODUCTS MARKET, BY END USER,
2022–2029 (USD MILLION) 367
TABLE 535 US: BIOCONJUGATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 367
TABLE 536 US: BIOCONJUGATION SERVICES MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 368
TABLE 537 US: BIOCONJUGATION SERVICES MARKET, BY CONJUGATION TYPE,
2022–2029 (USD MILLION) 368
TABLE 538 US: BIOCONJUGATION SERVICES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 368
TABLE 539 US: BIOCONJUGATION SERVICES MARKET, BY END USER,
2022–2029 (USD MILLION) 369
TABLE 540 CANADA: BIOCONJUGATION PRODUCTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 370
TABLE 541 CANADA: BIOCONJUGATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 370
TABLE 542 CANADA: BIOCONJUGATION REAGENTS & KITS MARKET, BY TYPE,
2022–2029 (USD MILLION) 370
TABLE 543 CANADA: BIOCONJUGATION LABELS MARKET, BY TYPE,
2022–2029 (USD MILLION) 371
TABLE 544 CANADA: BIOCONJUGATION INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 371
TABLE 545 CANADA: BIOCONJUGATION PRODUCTS MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 372
TABLE 546 CANADA: BIOCONJUGATION PRODUCTS MARKET, BY BIOMOLECULE TYPE,
2022–2029 (USD MILLION) 372
TABLE 547 CANADA: BIOCONJUGATION PRODUCTS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 372
TABLE 548 CANADA: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 373
TABLE 549 CANADA: BIOCONJUGATION PRODUCTS MARKET, BY END USER,
2022–2029 (USD MILLION) 373
TABLE 550 CANADA: BIOCONJUGATION SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 374
TABLE 551 CANADA: BIOCONJUGATION SERVICES MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 374
TABLE 552 CANADA: BIOCONJUGATION SERVICES MARKET, BY CONJUGATION TYPE,
2022–2029 (USD MILLION) 375
TABLE 553 CANADA: BIOCONJUGATION SERVICES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 375
TABLE 554 CANADA: BIOCONJUGATION SERVICES MARKET, BY END USER,
2022–2029 (USD MILLION) 375
TABLE 555 EUROPE: BIOCONJUGATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 376
TABLE 556 EUROPE: BIOCONJUGATION PRODUCTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 377
TABLE 557 EUROPE: BIOCONJUGATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 377
TABLE 558 EUROPE: BIOCONJUGATION PRODUCTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 377
TABLE 559 EUROPE: BIOCONJUGATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 378
TABLE 560 EUROPE: BIOCONJUGATION REAGENTS & KITS MARKET, BY TYPE,
2022–2029 (USD MILLION) 378
TABLE 561 EUROPE: BIOCONJUGATION LABELS MARKET, BY TYPE,
2022–2029 (USD MILLION) 378
TABLE 562 EUROPE: BIOCONJUGATION INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 379
TABLE 563 EUROPE: BIOCONJUGATION PRODUCTS MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 379
TABLE 564 EUROPE: BIOCONJUGATION PRODUCTS MARKET, BY BIOMOLECULE TYPE,
2022–2029 (USD MILLION) 380
TABLE 565 EUROPE: BIOCONJUGATION PRODUCTS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 380
TABLE 566 EUROPE: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 380
TABLE 567 EUROPE: BIOCONJUGATION PRODUCTS MARKET, BY END USER,
2022–2029 (USD MILLION) 381
TABLE 568 EUROPE: BIOCONJUGATION SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 381
TABLE 569 EUROPE: BIOCONJUGATION SERVICES MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 382
TABLE 570 EUROPE: BIOCONJUGATION SERVICES MARKET, BY CONJUGATION TYPE,
2022–2029 (USD MILLION) 382
TABLE 571 EUROPE: BIOCONJUGATION SERVICES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 382
TABLE 572 EUROPE: BIOCONJUGATION SERVICES MARKET, BY END USER,
2022–2029 (USD MILLION) 383
TABLE 573 EUROPE: KEY MACROINDICATORS 384
TABLE 574 GERMANY: BIOCONJUGATION PRODUCTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 385
TABLE 575 GERMANY: BIOCONJUGATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 385
TABLE 576 GERMANY: BIOCONJUGATION REAGENTS & KITS MARKET, BY TYPE,
2022–2029 (USD MILLION) 385
TABLE 577 GERMANY: BIOCONJUGATION LABELS MARKET, BY TYPE,
2022–2029 (USD MILLION) 386
TABLE 578 GERMANY: BIOCONJUGATION INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 386
TABLE 579 GERMANY: BIOCONJUGATION PRODUCTS MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 387
TABLE 580 GERMANY: BIOCONJUGATION PRODUCTS MARKET, BY BIOMOLECULE TYPE,
2022–2029 (USD MILLION) 387
TABLE 581 GERMANY: BIOCONJUGATION PRODUCTS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 387
TABLE 582 GERMANY: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 388
TABLE 583 GERMANY: BIOCONJUGATION PRODUCTS MARKET, BY END USER,
2022–2029 (USD MILLION) 388
TABLE 584 GERMANY: BIOCONJUGATION SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 389
TABLE 585 GERMANY: BIOCONJUGATION SERVICES MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 389
TABLE 586 GERMANY: BIOCONJUGATION SERVICES MARKET, BY CONJUGATION TYPE,
2022–2029 (USD MILLION) 390
TABLE 587 GERMANY: BIOCONJUGATION SERVICES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 390
TABLE 588 GERMANY: BIOCONJUGATION SERVICES MARKET, BY END USER,
2022–2029 (USD MILLION) 390
TABLE 589 UK: BIOCONJUGATION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 391
TABLE 590 UK: BIOCONJUGATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 391
TABLE 591 UK: BIOCONJUGATION REAGENTS & KITS MARKET, BY TYPE,
2022–2029 (USD MILLION) 392
TABLE 592 UK: BIOCONJUGATION LABELS MARKET, BY TYPE, 2022–2029 (USD MILLION) 392
TABLE 593 UK: BIOCONJUGATION INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 393
TABLE 594 UK: BIOCONJUGATION PRODUCTS MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 393
TABLE 595 UK: BIOCONJUGATION PRODUCTS MARKET, BY BIOMOLECULE TYPE,
2022–2029 (USD MILLION) 394
TABLE 596 UK: BIOCONJUGATION PRODUCTS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 394
TABLE 597 UK: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS,
BY TYPE, 2022–2029 (USD MILLION) 394
TABLE 598 UK: BIOCONJUGATION PRODUCTS MARKET, BY END USER,
2022–2029 (USD MILLION) 395
TABLE 599 UK: BIOCONJUGATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 395
TABLE 600 UK: BIOCONJUGATION SERVICES MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 395
TABLE 601 UK: BIOCONJUGATION SERVICES MARKET, BY CONJUGATION TYPE,
2022–2029 (USD MILLION) 396
TABLE 602 UK: BIOCONJUGATION SERVICES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 396
TABLE 603 UK: BIOCONJUGATION SERVICES MARKET, BY END USER,
2022–2029 (USD MILLION) 396
TABLE 604 FRANCE: BIOCONJUGATION PRODUCTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 397
TABLE 605 FRANCE: BIOCONJUGATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 398
TABLE 606 FRANCE: BIOCONJUGATION REAGENTS & KITS MARKET, BY TYPE,
2022–2029 (USD MILLION) 398
TABLE 607 FRANCE: BIOCONJUGATION LABELS MARKET, BY TYPE,
2022–2029 (USD MILLION) 398
TABLE 608 FRANCE: BIOCONJUGATION INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 399
TABLE 609 FRANCE: BIOCONJUGATION PRODUCTS MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 399
TABLE 610 FRANCE: BIOCONJUGATION PRODUCTS MARKET, BY BIOMOLECULE TYPE,
2022–2029 (USD MILLION) 400
TABLE 611 FRANCE: BIOCONJUGATION PRODUCTS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 400
TABLE 612 FRANCE: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 400
TABLE 613 FRANCE: BIOCONJUGATION PRODUCTS MARKET, BY END USER,
2022–2029 (USD MILLION) 401
TABLE 614 FRANCE: BIOCONJUGATION SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 401
TABLE 615 FRANCE: BIOCONJUGATION SERVICES MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 402
TABLE 616 FRANCE: BIOCONJUGATION SERVICES MARKET, BY CONJUGATION TYPE,
2022–2029 (USD MILLION) 402
TABLE 617 FRANCE: BIOCONJUGATION SERVICES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 402
TABLE 618 FRANCE: BIOCONJUGATION SERVICES MARKET, BY END USER,
2022–2029 (USD MILLION) 403
TABLE 619 ITALY: BIOCONJUGATION PRODUCTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 404
TABLE 620 ITALY: BIOCONJUGATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 404
TABLE 621 ITALY: BIOCONJUGATION REAGENTS & KITS MARKET, BY TYPE,
2022–2029 (USD MILLION) 404
TABLE 622 ITALY: BIOCONJUGATION LABELS MARKET, BY TYPE, 2022–2029 (USD MILLION) 405
TABLE 623 ITALY: BIOCONJUGATION INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 405
TABLE 624 ITALY: BIOCONJUGATION PRODUCTS MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 406
TABLE 625 ITALY: BIOCONJUGATION PRODUCTS MARKET, BY BIOMOLECULE TYPE,
2022–2029 (USD MILLION) 406
TABLE 626 ITALY: BIOCONJUGATION PRODUCTS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 406
TABLE 627 ITALY: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 407
TABLE 628 ITALY: BIOCONJUGATION PRODUCTS MARKET, BY END USER,
2022–2029 (USD MILLION) 407
TABLE 629 ITALY: BIOCONJUGATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 407
TABLE 630 ITALY: BIOCONJUGATION SERVICES MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 408
TABLE 631 ITALY: BIOCONJUGATION SERVICES MARKET, BY CONJUGATION TYPE,
2022–2029 (USD MILLION) 408
TABLE 632 ITALY: BIOCONJUGATION SERVICES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 408
TABLE 633 ITALY: BIOCONJUGATION SERVICES MARKET, BY END USER,
2022–2029 (USD MILLION) 409
TABLE 634 SPAIN: BIOCONJUGATION PRODUCTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 409
TABLE 635 SPAIN: BIOCONJUGATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 410
TABLE 636 SPAIN: BIOCONJUGATION REAGENTS & KITS MARKET, BY TYPE,
2022–2029 (USD MILLION) 410
TABLE 637 SPAIN: BIOCONJUGATION LABELS MARKET, BY TYPE, 2022–2029 (USD MILLION) 410
TABLE 638 SPAIN: BIOCONJUGATION INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 411
TABLE 639 SPAIN: BIOCONJUGATION PRODUCTS MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 411
TABLE 640 SPAIN: BIOCONJUGATION PRODUCTS MARKET, BY BIOMOLECULE TYPE,
2022–2029 (USD MILLION) 412
TABLE 641 SPAIN: BIOCONJUGATION PRODUCTS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 412
TABLE 642 SPAIN: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 412
TABLE 643 SPAIN: BIOCONJUGATION PRODUCTS MARKET, BY END USER,
2022–2029 (USD MILLION) 413
TABLE 644 SPAIN: BIOCONJUGATION SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 413
TABLE 645 SPAIN: BIOCONJUGATION SERVICES MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 414
TABLE 646 SPAIN: BIOCONJUGATION SERVICES MARKET, BY CONJUGATION TYPE,
2022–2029 (USD MILLION) 414
TABLE 647 SPAIN: BIOCONJUGATION SERVICES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 414
TABLE 648 SPAIN: BIOCONJUGATION SERVICES MARKET, BY END USER,
2022–2029 (USD MILLION) 415
TABLE 649 REST OF EUROPE: BIOCONJUGATION PRODUCTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 416
TABLE 650 REST OF EUROPE: BIOCONJUGATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 416
TABLE 651 REST OF EUROPE: BIOCONJUGATION REAGENTS & KITS MARKET, BY TYPE,
2022–2029 (USD MILLION) 416
TABLE 652 REST OF EUROPE: BIOCONJUGATION LABELS MARKET, BY TYPE,
2022–2029 (USD MILLION) 417
TABLE 653 REST OF EUROPE: BIOCONJUGATION INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 417
TABLE 654 REST OF EUROPE: BIOCONJUGATION PRODUCTS MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 418
TABLE 655 REST OF EUROPE: BIOCONJUGATION PRODUCTS MARKET, BY BIOMOLECULE TYPE, 2022–2029 (USD MILLION) 418
TABLE 656 REST OF EUROPE: BIOCONJUGATION PRODUCTS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 418
TABLE 657 REST OF EUROPE: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 419
TABLE 658 REST OF EUROPE: BIOCONJUGATION PRODUCTS MARKET, BY END USER,
2022–2029 (USD MILLION) 419
TABLE 659 REST OF EUROPE: BIOCONJUGATION SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 420
TABLE 660 REST OF EUROPE: BIOCONJUGATION SERVICES MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 420
TABLE 661 REST OF EUROPE: BIOCONJUGATION SERVICES MARKET, BY CONJUGATION TYPE, 2022–2029 (USD MILLION) 421
TABLE 662 REST OF EUROPE: BIOCONJUGATION SERVICES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 421
TABLE 663 REST OF EUROPE: BIOCONJUGATION SERVICES MARKET, BY END USER,
2022–2029 (USD MILLION) 421
TABLE 664 ASIA PACIFIC: BIOCONJUGATION MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 423
TABLE 665 ASIA PACIFIC: BIOCONJUGATION PRODUCTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 423
TABLE 666 ASIA PACIFIC: BIOCONJUGATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 424
TABLE 667 ASIA PACIFIC: BIOCONJUGATION PRODUCTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 424
TABLE 668 ASIA PACIFIC: BIOCONJUGATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 424
TABLE 669 ASIA PACIFIC: BIOCONJUGATION REAGENTS & KITS MARKET, BY TYPE,
2022–2029 (USD MILLION) 425
TABLE 670 ASIA PACIFIC: BIOCONJUGATION LABELS MARKET, BY TYPE,
2022–2029 (USD MILLION) 425
TABLE 671 ASIA PACIFIC: BIOCONJUGATION INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 426
TABLE 672 ASIA PACIFIC: BIOCONJUGATION PRODUCTS MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 426
TABLE 673 ASIA PACIFIC: BIOCONJUGATION PRODUCTS MARKET, BY BIOMOLECULE TYPE, 2022–2029 (USD MILLION) 427
TABLE 674 ASIA PACIFIC: BIOCONJUGATION PRODUCTS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 427
TABLE 675 ASIA PACIFIC: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 427
TABLE 676 ASIA PACIFIC: BIOCONJUGATION PRODUCTS MARKET, BY END USER,
2022–2029 (USD MILLION) 428
TABLE 677 ASIA PACIFIC: BIOCONJUGATION SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 428
TABLE 678 ASIA PACIFIC: BIOCONJUGATION SERVICES MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 429
TABLE 679 ASIA PACIFIC: BIOCONJUGATION SERVICES MARKET, BY CONJUGATION TYPE, 2022–2029 (USD MILLION) 429
TABLE 680 ASIA PACIFIC: BIOCONJUGATION SERVICES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 429
TABLE 681 ASIA PACIFIC: BIOCONJUGATION SERVICES MARKET, BY END USER,
2022–2029 (USD MILLION) 430
TABLE 682 ASIA PACIFIC: KEY MACROINDICATORS 431
TABLE 683 CHINA: BIOCONJUGATION PRODUCTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 432
TABLE 684 CHINA: BIOCONJUGATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 432
TABLE 685 CHINA: BIOCONJUGATION REAGENTS & KITS MARKET, BY TYPE,
2022–2029 (USD MILLION) 433
TABLE 686 CHINA: BIOCONJUGATION LABELS MARKET, BY TYPE, 2022–2029 (USD MILLION) 433
TABLE 687 CHINA: BIOCONJUGATION INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 434
TABLE 688 CHINA: BIOCONJUGATION PRODUCTS MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 434
TABLE 689 CHINA: BIOCONJUGATION PRODUCTS MARKET, BY BIOMOLECULE TYPE,
2022–2029 (USD MILLION) 435
TABLE 690 CHINA: BIOCONJUGATION PRODUCTS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 435
TABLE 691 CHINA: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 435
TABLE 692 CHINA: BIOCONJUGATION PRODUCTS MARKET, BY END USER,
2022–2029 (USD MILLION) 436
TABLE 693 CHINA: BIOCONJUGATION SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 436
TABLE 694 CHINA: BIOCONJUGATION SERVICES MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 437
TABLE 695 CHINA: BIOCONJUGATION SERVICES MARKET, BY CONJUGATION TYPE,
2022–2029 (USD MILLION) 437
TABLE 696 CHINA: BIOCONJUGATION SERVICES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 437
TABLE 697 CHINA: BIOCONJUGATION SERVICES MARKET, BY END USER,
2022–2029 (USD MILLION) 438
TABLE 698 JAPAN: BIOCONJUGATION PRODUCTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 439
TABLE 699 JAPAN: BIOCONJUGATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 439
TABLE 700 JAPAN: BIOCONJUGATION REAGENTS & KITS MARKET, BY TYPE,
2022–2029 (USD MILLION) 439
TABLE 701 JAPAN: BIOCONJUGATION LABELS MARKET, BY TYPE, 2022–2029 (USD MILLION) 440
TABLE 702 JAPAN: BIOCONJUGATION INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 440
TABLE 703 JAPAN: BIOCONJUGATION PRODUCTS MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 441
TABLE 704 JAPAN: BIOCONJUGATION PRODUCTS MARKET, BY BIOMOLECULE TYPE,
2022–2029 (USD MILLION) 441
TABLE 705 JAPAN: BIOCONJUGATION PRODUCTS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 441
TABLE 706 JAPAN: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 442
TABLE 707 JAPAN: BIOCONJUGATION PRODUCTS MARKET, BY END USER,
2022–2029 (USD MILLION) 442
TABLE 708 JAPAN: BIOCONJUGATION SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 443
TABLE 709 JAPAN: BIOCONJUGATION SERVICES MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 443
TABLE 710 JAPAN: BIOCONJUGATION SERVICES MARKET, BY CONJUGATION TYPE,
2022–2029 (USD MILLION) 444
TABLE 711 JAPAN: BIOCONJUGATION SERVICES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 444
TABLE 712 JAPAN: BIOCONJUGATION SERVICES MARKET, BY END USER,
2022–2029 (USD MILLION) 444
TABLE 713 INDIA: BIOCONJUGATION PRODUCTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 445
TABLE 714 INDIA: BIOCONJUGATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 446
TABLE 715 INDIA: BIOCONJUGATION REAGENTS & KITS MARKET, BY TYPE,
2022–2029 (USD MILLION) 446
TABLE 716 INDIA: BIOCONJUGATION LABELS MARKET, BY TYPE, 2022–2029 (USD MILLION) 446
TABLE 717 INDIA: BIOCONJUGATION INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 447
TABLE 718 INDIA: BIOCONJUGATION PRODUCTS MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 447
TABLE 719 INDIA: BIOCONJUGATION PRODUCTS MARKET, BY BIOMOLECULE TYPE,
2022–2029 (USD MILLION) 448
TABLE 720 INDIA: BIOCONJUGATION PRODUCTS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 448
TABLE 721 INDIA: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 448
TABLE 722 INDIA: BIOCONJUGATION PRODUCTS MARKET, BY END USER,
2022–2029 (USD MILLION) 449
TABLE 723 INDIA: BIOCONJUGATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 449
TABLE 724 INDIA: BIOCONJUGATION SERVICES MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 450
TABLE 725 INDIA: BIOCONJUGATION SERVICES MARKET, BY CONJUGATION TYPE,
2022–2029 (USD MILLION) 450
TABLE 726 INDIA: BIOCONJUGATION SERVICES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 450
TABLE 727 INDIA: BIOCONJUGATION SERVICES MARKET, BY END USER,
2022–2029 (USD MILLION) 451
TABLE 728 SOUTH KOREA: BIOCONJUGATION PRODUCTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 452
TABLE 729 SOUTH KOREA: BIOCONJUGATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 452
TABLE 730 SOUTH KOREA: BIOCONJUGATION REAGENTS & KITS MARKET, BY TYPE,
2022–2029 (USD MILLION) 452
TABLE 731 SOUTH KOREA: BIOCONJUGATION LABELS MARKET, BY TYPE,
2022–2029 (USD MILLION) 453
TABLE 732 SOUTH KOREA: BIOCONJUGATION INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 453
TABLE 733 SOUTH KOREA: BIOCONJUGATION PRODUCTS MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 454
TABLE 734 SOUTH KOREA: BIOCONJUGATION PRODUCTS MARKET, BY BIOMOLECULE TYPE, 2022–2029 (USD MILLION) 454
TABLE 735 SOUTH KOREA: BIOCONJUGATION PRODUCTS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 454
TABLE 736 SOUTH KOREA: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 455
TABLE 737 SOUTH KOREA: BIOCONJUGATION PRODUCTS MARKET, BY END USER,
2022–2029 (USD MILLION) 455
TABLE 738 SOUTH KOREA: BIOCONJUGATION SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 456
TABLE 739 SOUTH KOREA: BIOCONJUGATION SERVICES MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 456
TABLE 740 SOUTH KOREA: BIOCONJUGATION SERVICES MARKET, BY CONJUGATION TYPE, 2022–2029 (USD MILLION) 457
TABLE 741 SOUTH KOREA: BIOCONJUGATION SERVICES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 457
TABLE 742 SOUTH KOREA: BIOCONJUGATION SERVICES MARKET, BY END USER,
2022–2029 (USD MILLION) 457
TABLE 743 AUSTRALIA: BIOCONJUGATION PRODUCTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 458
TABLE 744 AUSTRALIA: BIOCONJUGATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 459
TABLE 745 AUSTRALIA: BIOCONJUGATION REAGENTS & KITS MARKET, BY TYPE,
2022–2029 (USD MILLION) 459
TABLE 746 AUSTRALIA: BIOCONJUGATION LABELS MARKET, BY TYPE,
2022–2029 (USD MILLION) 459
TABLE 747 AUSTRALIA: BIOCONJUGATION INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 460
TABLE 748 AUSTRALIA: BIOCONJUGATION PRODUCTS MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 460
TABLE 749 AUSTRALIA: BIOCONJUGATION PRODUCTS MARKET, BY BIOMOLECULE TYPE, 2022–2029 (USD MILLION) 461
TABLE 750 AUSTRALIA: BIOCONJUGATION PRODUCTS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 461
TABLE 751 AUSTRALIA: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 461
TABLE 752 AUSTRALIA: BIOCONJUGATION PRODUCTS MARKET, BY END USER,
2022–2029 (USD MILLION) 462
TABLE 753 AUSTRALIA: BIOCONJUGATION SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 462
TABLE 754 AUSTRALIA: BIOCONJUGATION SERVICES MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 463
TABLE 755 AUSTRALIA: BIOCONJUGATION SERVICES MARKET, BY CONJUGATION TYPE,
2022–2029 (USD MILLION) 463
TABLE 756 AUSTRALIA: BIOCONJUGATION SERVICES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 463
TABLE 757 AUSTRALIA: BIOCONJUGATION SERVICES MARKET, BY END USER,
2022–2029 (USD MILLION) 464
TABLE 758 REST OF ASIA PACIFIC: BIOCONJUGATION PRODUCTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 464
TABLE 759 REST OF ASIA PACIFIC: BIOCONJUGATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 465
TABLE 760 REST OF ASIA PACIFIC: BIOCONJUGATION REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 465
TABLE 761 REST OF ASIA PACIFIC: BIOCONJUGATION LABELS MARKET, BY TYPE,
2022–2029 (USD MILLION) 466
TABLE 762 REST OF ASIA PACIFIC: BIOCONJUGATION INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 466
TABLE 763 REST OF ASIA PACIFIC: BIOCONJUGATION PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 467
TABLE 764 REST OF ASIA PACIFIC: BIOCONJUGATION PRODUCTS MARKET, BY BIOMOLECULE TYPE, 2022–2029 (USD MILLION) 467
TABLE 765 REST OF ASIA PACIFIC: BIOCONJUGATION PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 467
TABLE 766 REST OF ASIA PACIFIC: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 468
TABLE 767 REST OF ASIA PACIFIC: BIOCONJUGATION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 468
TABLE 768 REST OF ASIA PACIFIC: BIOCONJUGATION SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 469
TABLE 769 REST OF ASIA PACIFIC: BIOCONJUGATION SERVICES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 469
TABLE 770 REST OF ASIA PACIFIC: BIOCONJUGATION SERVICES MARKET, BY CONJUGATION TYPE, 2022–2029 (USD MILLION) 470
TABLE 771 REST OF ASIA PACIFIC: BIOCONJUGATION SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 470
TABLE 772 REST OF ASIA PACIFIC: BIOCONJUGATION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 470
TABLE 773 LATIN AMERICA: BIOCONJUGATION MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 471
TABLE 774 LATIN AMERICA: BIOCONJUGATION PRODUCTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 471
TABLE 775 LATIN AMERICA: BIOCONJUGATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 472
TABLE 776 LATIN AMERICA: BIOCONJUGATION PRODUCTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 472
TABLE 777 LATIN AMERICA: BIOCONJUGATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 472
TABLE 778 LATIN AMERICA: BIOCONJUGATION REAGENTS & KITS MARKET, BY TYPE,
2022–2029 (USD MILLION) 473
TABLE 779 LATIN AMERICA: BIOCONJUGATION LABELS MARKET, BY TYPE,
2022–2029 (USD MILLION) 473
TABLE 780 LATIN AMERICA: BIOCONJUGATION INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 474
TABLE 781 LATIN AMERICA: BIOCONJUGATION PRODUCTS MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 474
TABLE 782 LATIN AMERICA: BIOCONJUGATION PRODUCTS MARKET, BY BIOMOLECULE TYPE, 2022–2029 (USD MILLION) 475
TABLE 783 LATIN AMERICA: BIOCONJUGATION PRODUCTS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 475
TABLE 784 LATIN AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 475
TABLE 785 LATIN AMERICA: BIOCONJUGATION PRODUCTS MARKET, BY END USER,
2022–2029 (USD MILLION) 476
TABLE 786 LATIN AMERICA: BIOCONJUGATION SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 476
TABLE 787 LATIN AMERICA: BIOCONJUGATION SERVICES MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 477
TABLE 788 LATIN AMERICA: BIOCONJUGATION SERVICES MARKET, BY CONJUGATION TYPE, 2022–2029 (USD MILLION) 477
TABLE 789 LATIN AMERICA: BIOCONJUGATION SERVICES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 477
TABLE 790 LATIN AMERICA: BIOCONJUGATION SERVICES MARKET, BY END USER,
2022–2029 (USD MILLION) 478
TABLE 791 LATIN AMERICA: KEY MACROINDICATORS 479
TABLE 792 BRAZIL: BIOCONJUGATION PRODUCTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 480
TABLE 793 BRAZIL: BIOCONJUGATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 480
TABLE 794 BRAZIL: BIOCONJUGATION REAGENTS & KITS MARKET, BY TYPE,
2022–2029 (USD MILLION) 480
TABLE 795 BRAZIL: BIOCONJUGATION LABELS MARKET, BY TYPE, 2022–2029 (USD MILLION) 481
TABLE 796 BRAZIL: BIOCONJUGATION INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 481
TABLE 797 BRAZIL: BIOCONJUGATION PRODUCTS MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 482
TABLE 798 BRAZIL: BIOCONJUGATION PRODUCTS MARKET, BY BIOMOLECULE TYPE,
2022–2029 (USD MILLION) 482
TABLE 799 BRAZIL: BIOCONJUGATION PRODUCTS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 482
TABLE 800 BRAZIL: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 483
TABLE 801 BRAZIL: BIOCONJUGATION PRODUCTS MARKET, BY END USER,
2022–2029 (USD MILLION) 483
TABLE 802 BRAZIL: BIOCONJUGATION SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 484
TABLE 803 BRAZIL: BIOCONJUGATION SERVICES MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 484
TABLE 804 BRAZIL: BIOCONJUGATION SERVICES MARKET, BY CONJUGATION TYPE,
2022–2029 (USD MILLION) 485
TABLE 805 BRAZIL: BIOCONJUGATION SERVICES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 485
TABLE 806 BRAZIL: BIOCONJUGATION SERVICES MARKET, BY END USER,
2022–2029 (USD MILLION) 485
TABLE 807 MEXICO: BIOCONJUGATION PRODUCTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 486
TABLE 808 MEXICO: BIOCONJUGATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 486
TABLE 809 MEXICO: BIOCONJUGATION REAGENTS & KITS MARKET, BY TYPE,
2022–2029 (USD MILLION) 487
TABLE 810 MEXICO: BIOCONJUGATION LABELS MARKET, BY TYPE, 2022–2029 (USD MILLION) 487
TABLE 811 MEXICO: BIOCONJUGATION INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 488
TABLE 812 MEXICO: BIOCONJUGATION PRODUCTS MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 488
TABLE 813 MEXICO: BIOCONJUGATION PRODUCTS MARKET, BY BIOMOLECULE TYPE,
2022–2029 (USD MILLION) 489
TABLE 814 MEXICO: BIOCONJUGATION PRODUCTS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 489
TABLE 815 MEXICO: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 489
TABLE 816 MEXICO: BIOCONJUGATION PRODUCTS MARKET, BY END USER,
2022–2029 (USD MILLION) 490
TABLE 817 MEXICO: BIOCONJUGATION SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 490
TABLE 818 MEXICO: BIOCONJUGATION SERVICES MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 491
TABLE 819 MEXICO: BIOCONJUGATION SERVICES MARKET, BY CONJUGATION TYPE,
2022–2029 (USD MILLION) 491
TABLE 820 MEXICO: BIOCONJUGATION SERVICES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 491
TABLE 821 MEXICO: BIOCONJUGATION SERVICES MARKET, BY END USER,
2022–2029 (USD MILLION) 492
TABLE 822 REST OF LATIN AMERICA: BIOCONJUGATION PRODUCTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 493
TABLE 823 REST OF LATIN AMERICA: BIOCONJUGATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 493
TABLE 824 REST OF LATIN AMERICA: BIOCONJUGATION REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 493
TABLE 825 REST OF LATIN AMERICA: BIOCONJUGATION LABELS MARKET, BY TYPE,
2022–2029 (USD MILLION) 494
TABLE 826 REST OF LATIN AMERICA: BIOCONJUGATION INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 494
TABLE 827 REST OF LATIN AMERICA: BIOCONJUGATION PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 495
TABLE 828 REST OF LATIN AMERICA: BIOCONJUGATION PRODUCTS MARKET,
BY BIOMOLECULE TYPE, 2022–2029 (USD MILLION) 495
TABLE 829 REST OF LATIN AMERICA: BIOCONJUGATION PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 495
TABLE 830 REST OF LATIN AMERICA: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 496
TABLE 831 REST OF LATIN AMERICA: BIOCONJUGATION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 496
TABLE 832 REST OF LATIN AMERICA: BIOCONJUGATION SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 497
TABLE 833 REST OF LATIN AMERICA: BIOCONJUGATION SERVICES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 497
TABLE 834 REST OF LATIN AMERICA: BIOCONJUGATION SERVICES MARKET, BY CONJUGATION TYPE, 2022–2029 (USD MILLION) 498
TABLE 835 REST OF LATIN AMERICA: BIOCONJUGATION SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 498
TABLE 836 REST OF LATIN AMERICA: BIOCONJUGATION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 498
TABLE 837 MIDDLE EAST: BIOCONJUGATION MARKET, BY REGION,
2022–2029 (USD MILLION) 499
TABLE 838 MIDDLE EAST: BIOCONJUGATION PRODUCTS MARKET, BY REGION,
2022–2029 (USD MILLION) 499
TABLE 839 MIDDLE EAST: BIOCONJUGATION SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION) 499
TABLE 840 MIDDLE EAST: BIOCONJUGATION PRODUCTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 500
TABLE 841 MIDDLE EAST: BIOCONJUGATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 500
TABLE 842 MIDDLE EAST: BIOCONJUGATION REAGENTS & KITS MARKET, BY TYPE,
2022–2029 (USD MILLION) 500
TABLE 843 MIDDLE EAST: BIOCONJUGATION LABELS MARKET, BY TYPE,
2022–2029 (USD MILLION) 501
TABLE 844 MIDDLE EAST: BIOCONJUGATION INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 501
TABLE 845 MIDDLE EAST: BIOCONJUGATION PRODUCTS MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 502
TABLE 846 MIDDLE EAST: BIOCONJUGATION PRODUCTS MARKET, BY BIOMOLECULE TYPE, 2022–2029 (USD MILLION) 502
TABLE 847 MIDDLE EAST: BIOCONJUGATION PRODUCTS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 503
TABLE 848 MIDDLE EAST: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 503
TABLE 849 MIDDLE EAST: BIOCONJUGATION PRODUCTS MARKET, BY END USER,
2022–2029 (USD MILLION) 503
TABLE 850 MIDDLE EAST: BIOCONJUGATION SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 504
TABLE 851 MIDDLE EAST: BIOCONJUGATION SERVICES MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 504
TABLE 852 MIDDLE EAST: BIOCONJUGATION SERVICES MARKET, BY CONJUGATION TYPE, 2022–2029 (USD MILLION) 505
TABLE 853 MIDDLE EAST: BIOCONJUGATION SERVICES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 505
TABLE 854 MIDDLE EAST: BIOCONJUGATION SERVICES MARKET, BY END USER,
2022–2029 (USD MILLION) 505
TABLE 855 MIDDLE EAST: KEY MACROINDICATORS 506
TABLE 856 GCC COUNTRIES: BIOCONJUGATION MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 507
TABLE 857 GCC COUNTRIES: BIOCONJUGATION PRODUCTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 507
TABLE 858 GCC COUNTRIES: BIOCONJUGATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 508
TABLE 859 GCC COUNTRIES: BIOCONJUGATION PRODUCTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 508
TABLE 860 GCC COUNTRIES: BIOCONJUGATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 508
TABLE 861 GCC COUNTRIES: BIOCONJUGATION REAGENTS & KITS MARKET, BY TYPE,
2022–2029 (USD MILLION) 509
TABLE 862 GCC COUNTRIES: BIOCONJUGATION LABELS MARKET, BY TYPE,
2022–2029 (USD MILLION) 509
TABLE 863 GCC COUNTRIES: BIOCONJUGATION INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 510
TABLE 864 GCC COUNTRIES: BIOCONJUGATION PRODUCTS MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 510
TABLE 865 GCC COUNTRIES: BIOCONJUGATION PRODUCTS MARKET, BY BIOMOLECULE TYPE, 2022–2029 (USD MILLION) 511
TABLE 866 GCC COUNTRIES: BIOCONJUGATION PRODUCTS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 511
TABLE 867 GCC COUNTRIES: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 511
TABLE 868 GCC COUNTRIES: BIOCONJUGATION PRODUCTS MARKET, BY END USER,
2022–2029 (USD MILLION) 512
TABLE 869 GCC COUNTRIES: BIOCONJUGATION SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 512
TABLE 870 GCC COUNTRIES: BIOCONJUGATION SERVICES MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 513
TABLE 871 GCC COUNTRIES: BIOCONJUGATION SERVICES MARKET, BY CONJUGATION TYPE, 2022–2029 (USD MILLION) 513
TABLE 872 GCC COUNTRIES: BIOCONJUGATION SERVICES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 513
TABLE 873 GCC COUNTRIES: BIOCONJUGATION SERVICES MARKET, BY END USER,
2022–2029 (USD MILLION) 514
TABLE 874 KINGDOM OF SAUDI ARABIA: BIOCONJUGATION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 514
TABLE 875 KINGDOM OF SAUDI ARABIA: BIOCONJUGATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 515
TABLE 876 KINGDOM OF SAUDI ARABIA: BIOCONJUGATION REAGENTS & KITS MARKET,
BY TYPE, 2022–2029 (USD MILLION) 515
TABLE 877 KINGDOM OF SAUDI ARABIA: BIOCONJUGATION LABELS MARKET, BY TYPE,
2022–2029 (USD MILLION) 516
TABLE 878 KINGDOM OF SAUDI ARABIA: BIOCONJUGATION INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 516
TABLE 879 KINGDOM OF SAUDI ARABIA: BIOCONJUGATION PRODUCTS MARKET,
BY TECHNIQUE, 2022–2029 (USD MILLION) 517
TABLE 880 KINGDOM OF SAUDI ARABIA: BIOCONJUGATION PRODUCTS MARKET,
BY BIOMOLECULE TYPE, 2022–2029 (USD MILLION) 517
TABLE 881 KINGDOM OF SAUDI ARABIA: BIOCONJUGATION PRODUCTS MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 517
TABLE 882 KINGDOM OF SAUDI ARABIA: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 518
TABLE 883 KINGDOM OF SAUDI ARABIA: BIOCONJUGATION PRODUCTS MARKET,
BY END USER, 2022–2029 (USD MILLION) 518
TABLE 884 KINGDOM OF SAUDI ARABIA: BIOCONJUGATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 519
TABLE 885 KINGDOM OF SAUDI ARABIA: BIOCONJUGATION SERVICES MARKET,
BY TECHNIQUE, 2022–2029 (USD MILLION) 519
TABLE 886 KINGDOM OF SAUDI ARABIA: BIOCONJUGATION SERVICES MARKET,
BY CONJUGATION TYPE, 2022–2029 (USD MILLION) 520
TABLE 887 KINGDOM OF SAUDI ARABIA: BIOCONJUGATION SERVICES MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 520
TABLE 888 KINGDOM OF SAUDI ARABIA: BIOCONJUGATION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 520
TABLE 889 UNITED ARAB EMIRATES: BIOCONJUGATION PRODUCTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 521
TABLE 890 UNITED ARAB EMIRATES: BIOCONJUGATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 521
TABLE 891 UNITED ARAB EMIRATES: BIOCONJUGATION REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 522
TABLE 892 UNITED ARAB EMIRATES: BIOCONJUGATION LABELS MARKET, BY TYPE,
2022–2029 (USD MILLION) 522
TABLE 893 UNITED ARAB EMIRATES: BIOCONJUGATION INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 523
TABLE 894 UNITED ARAB EMIRATES: BIOCONJUGATION PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 523
TABLE 895 UNITED ARAB EMIRATES: BIOCONJUGATION PRODUCTS MARKET,
BY BIOMOLECULE TYPE, 2022–2029 (USD MILLION) 524
TABLE 896 UNITED ARAB EMIRATES: BIOCONJUGATION PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 524
TABLE 897 UNITED ARAB EMIRATES: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 524
TABLE 898 UNITED ARAB EMIRATES: BIOCONJUGATION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 525
TABLE 899 UNITED ARAB EMIRATES: BIOCONJUGATION SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 525
TABLE 900 UNITED ARAB EMIRATES: BIOCONJUGATION SERVICES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 526
TABLE 901 UNITED ARAB EMIRATES: BIOCONJUGATION SERVICES MARKET, BY CONJUGATION TYPE, 2022–2029 (USD MILLION) 526
TABLE 902 UNITED ARAB EMIRATES: BIOCONJUGATION SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 526
TABLE 903 UNITED ARAB EMIRATES: BIOCONJUGATION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 527
TABLE 904 OTHER GCC COUNTRIES: BIOCONJUGATION PRODUCTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 528
TABLE 905 OTHER GCC COUNTRIES: BIOCONJUGATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 528
TABLE 906 OTHER GCC COUNTRIES: BIOCONJUGATION REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 528
TABLE 907 OTHER GCC COUNTRIES: BIOCONJUGATION LABELS MARKET, BY TYPE,
2022–2029 (USD MILLION) 529
TABLE 908 OTHER GCC COUNTRIES: BIOCONJUGATION INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 529
TABLE 909 OTHER GCC COUNTRIES: BIOCONJUGATION PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 530
TABLE 910 OTHER GCC COUNTRIES: BIOCONJUGATION PRODUCTS MARKET,
BY BIOMOLECULE TYPE, 2022–2029 (USD MILLION) 530
TABLE 911 OTHER GCC COUNTRIES: BIOCONJUGATION PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 530
TABLE 912 OTHER GCC COUNTRIES: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 531
TABLE 913 OTHER GCC COUNTRIES: BIOCONJUGATION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 531
TABLE 914 OTHER GCC COUNTRIES: BIOCONJUGATION SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 532
TABLE 915 OTHER GCC COUNTRIES: BIOCONJUGATION SERVICES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 532
TABLE 916 OTHER GCC COUNTRIES: BIOCONJUGATION SERVICES MARKET, BY CONJUGATION TYPE, 2022–2029 (USD MILLION) 533
TABLE 917 OTHER GCC COUNTRIES: BIOCONJUGATION SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 533
TABLE 918 OTHER GCC COUNTRIES: BIOCONJUGATION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 533
TABLE 919 REST OF MIDDLE EAST: BIOCONJUGATION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 534
TABLE 920 REST OF MIDDLE EAST: BIOCONJUGATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 535
TABLE 921 REST OF MIDDLE EAST: BIOCONJUGATION REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 535
TABLE 922 REST OF MIDDLE EAST: BIOCONJUGATION LABELS MARKET, BY TYPE,
2022–2029 (USD MILLION) 536
TABLE 923 REST OF MIDDLE EAST: BIOCONJUGATION INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 536
TABLE 924 REST OF MIDDLE EAST: BIOCONJUGATION PRODUCTS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 537
TABLE 925 REST OF MIDDLE EAST: BIOCONJUGATION PRODUCTS MARKET, BY BIOMOLECULE TYPE, 2022–2029 (USD MILLION) 537
TABLE 926 REST OF MIDDLE EAST: BIOCONJUGATION PRODUCTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 537
TABLE 927 REST OF MIDDLE EAST: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 538
TABLE 928 REST OF MIDDLE EAST: BIOCONJUGATION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 538
TABLE 929 REST OF MIDDLE EAST: BIOCONJUGATION SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 539
TABLE 930 REST OF MIDDLE EAST: BIOCONJUGATION SERVICES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 539
TABLE 931 REST OF MIDDLE EAST: BIOCONJUGATION SERVICES MARKET, BY CONJUGATION TYPE, 2022–2029 (USD MILLION) 540
TABLE 932 REST OF MIDDLE EAST: BIOCONJUGATION SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 540
TABLE 933 REST OF MIDDLE EAST: BIOCONJUGATION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 540
TABLE 934 AFRICA: BIOCONJUGATION PRODUCTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 541
TABLE 935 AFRICA: BIOCONJUGATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 541
TABLE 936 AFRICA: BIOCONJUGATION REAGENTS & KITS MARKET, BY TYPE,
2022–2029 (USD MILLION) 542
TABLE 937 AFRICA: BIOCONJUGATION LABELS MARKET, BY TYPE, 2022–2029 (USD MILLION) 542
TABLE 938 AFRICA: BIOCONJUGATION INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 543
TABLE 939 AFRICA: BIOCONJUGATION PRODUCTS MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 543
TABLE 940 AFRICA: BIOCONJUGATION PRODUCTS MARKET, BY BIOMOLECULE TYPE,
2022–2029 (USD MILLION) 544
TABLE 941 AFRICA: BIOCONJUGATION PRODUCTS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 544
TABLE 942 AFRICA: BIOCONJUGATION PRODUCTS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 544
TABLE 943 AFRICA: BIOCONJUGATION PRODUCTS MARKET, BY END USER,
2022–2029 (USD MILLION) 545
TABLE 944 AFRICA: BIOCONJUGATION SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION) 545
TABLE 945 AFRICA: BIOCONJUGATION SERVICES MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 546
TABLE 946 AFRICA: BIOCONJUGATION SERVICES MARKET, BY CONJUGATION TYPE,
2022–2029 (USD MILLION) 546
TABLE 947 AFRICA: BIOCONJUGATION SERVICES MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 546
TABLE 948 AFRICA: BIOCONJUGATION SERVICES MARKET, BY END USER,
2022–2029 (USD MILLION) 547
TABLE 949 AFRICA: MACROINDICATORS 548
TABLE 950 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES 550
TABLE 951 BIOCONJUGATION MARKET: DEGREE OF COMPETITION 553
TABLE 952 BIOCONJUGATION MARKET: PRODUCT/SERVICE FOOTPRINT 557
TABLE 953 BIOCONJUGATION MARKET: APPLICATION FOOTPRINT 558
TABLE 954 BIOCONJUGATION MARKET: END-USER FOOTPRINT 559
TABLE 955 BIOCONJUGATION MARKET: REGION FOOTPRINT 560
TABLE 956 BIOCONJUGATION MARKET: DETAILED LIST OF KEY STARTUPS/SMES 564
TABLE 957 BIOCONJUGATION MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 565
TABLE 958 BIOCONJUGATION MARKET: PRODUCT/SERVICE LAUNCHES,
JANUARY 2021–AUGUST 2024 569
TABLE 959 BIOCONJUGATION MARKET: DEALS, JANUARY 2021–AUGUST 2024 570
TABLE 960 BIOCONJUGATION MARKET: EXPANSIONS, JANUARY 2021–AUGUST 2024 571
TABLE 961 DANAHER CORPORATION: COMPANY OVERVIEW 573
TABLE 962 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED 574
TABLE 963 DANAHER CORPORATION: PRODUCT/SERVICE LAUNCHES, JANUARY 2021−AUGUST 2024 582
TABLE 964 DANAHER CORPORATION: DEALS, JANUARY 2021−AUGUST 2024 583
TABLE 965 DANAHER CORPORATION: EXPANSIONS, JANUARY 2021–JUNE 2024 583
TABLE 966 LONZA: COMPANY OVERVIEW 586
TABLE 967 LONZA: PRODUCTS/SERVICES OFFERED 587
TABLE 968 LONZA: DEALS, JANUARY 2021–JUNE 2024 588
TABLE 969 LONZA: EXPANSIONS, JANUARY 2021–JUNE 2024 588
TABLE 970 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 590
TABLE 971 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED 591
TABLE 972 THERMO FISHER SCIENTIFIC INC.: PRODUCT/SERVICE LAUNCHES,
JANUARY 2021–JUNE 2024 597
TABLE 973 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–JUNE 2024 598
TABLE 974 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021–JUNE 2024 598
TABLE 975 MERCK KGAA: COMPANY OVERVIEW 601
TABLE 976 MERCK KGAA: PRODUCTS/SERVICES OFFERED 602
TABLE 977 MERCK KGAA: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–JUNE 2024 606
TABLE 978 MERCK KGAA: DEALS, JANUARY 2021–JUNE 2024 607
TABLE 979 MERCK KGAA: EXPANSIONS, JANUARY 2021–JUNE 2024 607
TABLE 980 ABBVIE INC.: COMPANY OVERVIEW 610
TABLE 981 ABBVIE INC.: PRODUCTS/SERVICES OFFERED 611
TABLE 982 ABBVIE INC.: DEALS, JANUARY 2021–JUNE 2024 611
TABLE 983 ABBVIE INC.: EXPANSIONS, JANUARY 2021–JUNE 2024 612
TABLE 984 WUXI BIOLOGICS (CAYMAN) INC.: COMPANY OVERVIEW 613
TABLE 985 WUXI BIOLOGICS (CAYMAN) INC.: PRODUCTS/SERVICES OFFERED 614
TABLE 986 WUXI BIOLOGICS (CAYMAN) INC.: DEALS, JANUARY 2021–JUNE 2024 615
TABLE 987 WUXI BIOLOGICS (CAYMAN) INC.: EXPANSIONS, JANUARY 2021–JUNE 2024 616
TABLE 988 SARTORIUS AG: COMPANY OVERVIEW 617
TABLE 989 SARTORIUS AG: PRODUCTS/SERVICES OFFERED 618
TABLE 990 SARTORIUS AG: DEALS, JANUARY 2021–JUNE 2024 620
TABLE 991 SARTORIUS AG: EXPANSIONS, JANUARY 2021–JUNE 2024 621
TABLE 992 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 623
TABLE 993 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED 624
TABLE 994 CATALENT, INC.: COMPANY OVERVIEW 628
TABLE 995 CATALENT, INC.: PRODUCTS/SERVICES OFFERED 629
TABLE 996 CATALENT, INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–JUNE 2024 630
TABLE 997 CATALENT, INC.: DEALS, JANUARY 2021–JUNE 2024 630
TABLE 998 CATALENT, INC.: EXPANSIONS, JANUARY 2021–AUGUST 2024 631
TABLE 999 BECKTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 632
TABLE 1000 BD: PRODUCTS/SERVICES OFFERED 633
TABLE 1001 BD: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–AUGUST 2024 635
TABLE 1002 BD: DEALS, JANUARY 2021–AUGUST 2024 635
TABLE 1003 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 636
TABLE 1004 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED 637
TABLE 1005 AGILENT TECHNOLOGIES, INC.: PRODUCT/SERVICE LAUNCHES,
JANUARY 2021–AUGUST 2024 638
TABLE 1006 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021–AUGUST 2024 639
TABLE 1007 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2021–AUGUST 2024 640
TABLE 1008 PROMEGA CORPORATION: COMPANY OVERVIEW 641
TABLE 1009 PROMEGA CORPORATION: PRODUCTS/SERVICES OFFERED 641
TABLE 1010 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 642
TABLE 1011 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED 643
TABLE 1012 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW 645
TABLE 1013 CHARLES RIVER LABORATORIES: PRODUCTS/SERVICES OFFERED 646
TABLE 1014 CHARLES RIVER LABORATORIES: DEALS, JANUARY 2021–AUGUST 2024 647
TABLE 1015 GENSCRIPT BIOTECH CORPORATION: COMPANY OVERVIEW 648
TABLE 1016 GENSCRIPT BIOTECH CORPORATION: PRODUCTS/SERVICES OFFERED 649
TABLE 1017 GENSCRIPT BIOTECH CORPORATION: DEALS, JANUARY 2021–AUGUST 2024 650
TABLE 1018 PIRAMAL PHARMA LIMITED: COMPANY OVERVIEW 651
TABLE 1019 PIRAMAL PHARMA LIMITED: PRODUCTS/SERVICES OFFERED 652
TABLE 1020 PIRAMAL PHARMA LIMITED: PRODUCT/SERVICE LAUNCHES,
JANUARY 2021–AUGUST 2024 653
TABLE 1021 PIRAMAL PHARMA LIMITED: EXPANSIONS, JANUARY 2021–AUGUST 2024 653
TABLE 1022 ABZENA LTD.: COMPANY OVERVIEW 654
TABLE 1023 NEW ENGLAND BIOLABS: COMPANY OVERVIEW 655
TABLE 1024 BIOSYNTH: COMPANY OVERVIEW 656
TABLE 1025 CELL SIGNALING TECHNOLOGY, INC.: COMPANY OVERVIEW 657
TABLE 1026 CREATIVE BIOLABS: COMPANY OVERVIEW 658
TABLE 1027 FORMOSA LABORATORIES INC.: COMPANY OVERVIEW 659
TABLE 1028 NJ BIO, INC.: COMPANY OVERVIEW 660
TABLE 1029 ROCKLAND IMMUNOCHEMICALS, INC.: COMPANY OVERVIEW 661
TABLE 1030 SHANGHAI CHEMPARTNER: COMPANY OVERVIEW 662
TABLE 1031 STERLING PHARMA SOLUTIONS LIMITED: COMPANY OVERVIEW 662
TABLE 1032 SYNGENE INTERNATIONAL LIMITED: COMPANY OVERVIEW 663
TABLE 1033 TOKYO CHEMICAL INDUSTRY CO., LTD.: COMPANY OVERVIEW 664
TABLE 1034 VECTOR LABORATORIES, INC.: COMPANY OVERVIEW 665
LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN 62
FIGURE 2 BREAKDOWN OF PRIMARIES: BIOCONJUGATION MARKET 64
FIGURE 3 BIOCONJUGATION MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023 65
FIGURE 4 GLOBAL MARKET SIZE ESTIMATION APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023 66
FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS (2023) 66
FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 68
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 68
FIGURE 8 BIOCONJUGATION MARKET: CAGR PROJECTIONS 70
FIGURE 9 DATA TRIANGULATION METHODOLOGY 72
FIGURE 10 BIOCONJUGATION PRODUCTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 75
FIGURE 11 BIOCONJUGATION PRODUCTS MARKET, BY TECHNIQUE,
2024 VS. 2029 (USD MILLION) 76
FIGURE 12 BIOCONJUGATION PRODUCTS MARKET, BY BIOMOLECULE TYPE,
2024 VS. 2029 (USD MILLION) 76
FIGURE 13 BIOCONJUGATION PRODUCTS MARKET, BY APPLICATION,
2024 VS. 2029 (USD MILLION) 77
FIGURE 14 BIOCONJUGATION PRODUCTS MARKET, BY END USER,
2024 VS. 2029 (USD MILLION) 77
FIGURE 15 BIOCONJUGATION SERVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 78
FIGURE 16 BIOCONJUGATION SERVICES MARKET, BY TECHNIQUE,
2024 VS. 2029 (USD MILLION) 79
FIGURE 17 BIOCONJUGATION SERVICES MARKET, BY CONJUGATION TYPE,
2024 VS. 2029 (USD MILLION) 79
FIGURE 18 BIOCONJUGATION SERVICES MARKET, BY APPLICATION,
2024 VS. 2029 (USD MILLION) 80
FIGURE 19 BIOCONJUGATION SERVICES MARKET, BY END USER,
2024 VS. 2029 (USD MILLION) 81
FIGURE 20 GEOGRAPHIC SNAPSHOT OF BIOCONJUGATION MARKET 82
FIGURE 21 GROWING DEMAND FOR TARGETED THERAPIES TO DRIVE MARKET 83
FIGURE 22 THERAPEUTICS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN US
IN 2023 84
FIGURE 23 CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 84
FIGURE 24 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 85
FIGURE 25 CUSTOM SYNTHESIS & CONJUGATION SERVICES SEGMENT ACCOUNTED FOR LARGER MARKET SHARE IN 2023 85
FIGURE 26 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 86
FIGURE 27 BIOCONJUGATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 88
FIGURE 28 COMMERCIAL ANTIBODY-DRUG CONJUGATE (ADC) INVESTIGATIONAL NEW DRUG (IND) SUBMISSIONS, 1993−2024 92
FIGURE 29 REVENUE SHIFTS IN BIOCONJUGATION MARKET 97
FIGURE 30 BIOCONJUGATION MARKET: SUPPLY CHAIN ANALYSIS 100
FIGURE 31 BIOCONJUGATION MARKET: VALUE CHAIN ANALYSIS 102
FIGURE 32 BIOCONJUGATION MARKET: ECOSYSTEM MARKET MAP 104
FIGURE 33 NUMBER OF PATENTS APPLICATIONS/GRANTED, 2014−2024 111
FIGURE 34 BIOCONJUGATION MARKET: PORTER’S FIVE FORCES ANALYSIS 120
FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF
BIOCONJUGATION PRODUCTS 122
FIGURE 36 KEY BUYING CRITERIA FOR BIOCONJUGATION PRODUCTS 123
FIGURE 37 BIOCONJUGATION MARKET: IMPACT OF AI 128
FIGURE 38 ADCS ENTERING CLINICAL TRIALS, 2012−2022 243
FIGURE 39 NUMBER OF DOCUMENTS (JOURNAL ARTICLES AND PATENTS) IN CAS CONTENT COLLECTION FOR ADC R&D 333
FIGURE 40 NORTH AMERICA: BIOCONJUGATION MARKET SNAPSHOT 354
FIGURE 41 US: FUNDING BY NIH, 2014–2024 363
FIGURE 42 ASIA PACIFIC: BIOCONJUGATION MARKET SNAPSHOT 422
FIGURE 43 REVENUE ANALYSIS OF KEY PLAYERS IN BIOCONJUGATION MARKET, 2019–2023 551
FIGURE 44 MARKET SHARE ANALYSIS OF KEY PLAYERS IN BIOCONJUGATION MARKET, 2023 552
FIGURE 45 BIOCONJUGATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 555
FIGURE 46 BIOCONJUGATION MARKET: COMPANY FOOTPRINT 556
FIGURE 47 BIOCONJUGATION MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2023 563
FIGURE 48 EV/EBITDA OF KEY VENDORS 566
FIGURE 49 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 567
FIGURE 50 BIOCONJUGATION MARKET: BRAND/PRODUCT/SERVICE COMPARISON 568
FIGURE 51 DANAHER CORPORATION: COMPANY SNAPSHOT (2023) 574
FIGURE 52 LONZA: COMPANY SNAPSHOT (2023) 587
FIGURE 53 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023) 591
FIGURE 54 MERCK KGAA: COMPANY SNAPSHOT (2023) 602
FIGURE 55 ABBVIE INC.: COMPANY SNAPSHOT (2023) 610
FIGURE 56 WUXI BIOLOGICS (CAYMAN) INC.: COMPANY SNAPSHOT (2023) 614
FIGURE 57 SARTORIUS AG: COMPANY SNAPSHOT (2023) 618
FIGURE 58 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023) 624
FIGURE 59 CATALENT, INC.: COMPANY SNAPSHOT (2023) 629
FIGURE 60 BECKTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2023) 633
FIGURE 61 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023) 637
FIGURE 62 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2023) 643
FIGURE 63 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2023) 646
FIGURE 64 GENSCRIPT BIOTECH CORPORATION: COMPANY SNAPSHOT (2023) 649
FIGURE 65 PIRAMAL PHARMA LIMITED: COMPANY SNAPSHOT (2023) 652
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11